腎と透析　Vol.76　2014年増刊号　透析・腎移植のすべて

歴史

P.18 掲載の参考文献

1) 第50回日本透析医学会編 : DVDでみる透析の歴史, 2005

 

2) 北岡建樹 : 透析の歴史. 透析用語百科事典, 永井書店, 大阪, 2012

 

3) 川口良人 : わが国における腹膜透析の歩みと世界に向けての展開. 腎臓 34 (2) : 134-143, 2011

 

P.24 掲載の参考文献

1) Kusunoki T, Inoue H, Takayangi T, et al : An experience of renal homotransplantations on human. Acta Medica et Biologica 4 : 227-233, 1956

 

2) 高橋公太編 : 腎移植のすべて, メディカル・ビュー社, 東京, 2009

 

3) Murray JE, Harrison JH : Surgical management of fifty patients with kidney transplants including eighteen pairs of twins. Am J Surg 15 : 205-218, 1963

 

4) Calne RY, Alexandre GPJ, Murray JE : A study of the effect of drug in prolonging survival of homologous renal transplants in dog. Ann New York Acad Sci 99 : 743-761, 1962

 

5) Takahashi K, Saito K, Takahara S, et al : The Japanese ABO-incompatible Kidney Transplantation Committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 : 1089-1096, 2004

PubMed

CKD, AKI

P.30 掲載の参考文献

1) 川口良人 : 透析導入ガイドラインの策定と追跡調査に関する研究. 平成4年度厚生科学研究 腎不全医療 事業報告書, 156-164, 1993

 

2) 川口良人 : 慢性透析の導入基準と追跡調査による妥当性の検討. 平成6年度厚生科学研究 腎不全医療事業報告書, 84-87, 1995

 

3) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析療法の現況 (2006年末12月31日現在), pp45-53, 2007

 

4) 政金生人, 渡邊有三, 平方秀樹, 山縣邦弘, 他 : 日本透析医学会「維持血液透析ガイドライン血液透析導入」維持血液透析ガイドライン. 透析会誌 46 (12) : 1107-1158, 2013

 

5) 厚生省健康政策局監修, 柳田邦男編 : 元気が出るインフォームド・コンセント, 中央法規出版, 東京, 1996

 

6) 中山昌明, 川西秀樹, 友雅司, 他 : 2009年版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 : 285-315, 2009

 

7) 佐中孜 : CKD早期発見・治療ベストガイド, 医学書院, 東京, 2013

 

P.34 掲載の参考文献

1) Bellomo R, Ronco C, Kellum JA, et al : Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs : the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 : R204-R212, 2004

PubMed

2) Mehta RL, Kellum JA, Shah SV, et al : Acute Kidney Injury Network : report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 : R31, 2007

PubMed

3) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group : KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int (suppl 2) : 1-138, 2012

 

4) Uchino S, Bellomo R, Morimatsu H, et al : Discontinuation of continuous renal replacement therapy : a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37 : 2576-2582, 2009

PubMed

5) The VA/NIH Acute Renal Failure Trial Network : Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury. N Engl J Med 359 : 7-20, 2008

PubMed

6) Prowle JR, Schneider A, Bellomo R : Clinical review : Optimal dose of continuous renal replacement therapy in acute kidney injury. Crit Care 15 : 207-214, 2011

PubMed

P.38 掲載の参考文献

1) National Kidney Foundation : K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Am J Kidney Dis 39 (2 suppl) : 5-266, 2002

 

2) Wolfe R, et al : Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 : 1725-1730, 1999

PubMed

3) Abimereki D, et al : Risk of end-stage renal disease following live kidney donation. JAMA 311 (6) : 579-586, 2014

 

現状と問題点

P.44 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在). 透析会誌 47 (1) : 1-56, 2014

 

2) 中井滋, 若井建志, 山縣邦弘, 他 : わが国の慢性維持透析人口将来推計の試み. 透析会誌 45 : 599-613, 2012

 

3) Robinson BM, Zhang J, Morgenstern H, et al : Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 85 : 158-165, 2014

PubMed

4) 日本透析医学会 : 維持血液透析ガイドライン : 血液透析処方. 透析会誌 46 (7) : 587-632, 2013

 

5) 日本透析医学会 : 慢性腎臓病患者における腎性貧血治療のガイドライン. 透析会誌 41 (10) : 661-716, 2008

 

6) 日本透析医学会 : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 透析会誌 45 (4) : 301-356, 2012

 

7) 日本透析医学会 : 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 44 (5) : 337-425, 2011

 

8) 日本透析医学会 : 血液透析患者の糖尿病治療ガイド 2012. 透析会誌 46 (3) : 311-357, 2013

 

9) 日本透析医学会 : 透析患者のC型ウイルス肝炎治療ガイドライン. 透析会誌 44 (6) : 481-531, 2011

 

10) 日本透析医学会, 日本透析医会 : HIV感染患者透析医療ガイドライン. 日透医誌 25 : 360-378, 2010

 

11) Maduell F, Moreso F, Pons M : High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients. J Am Soc Nephrol 24 : 487-497, 2013

PubMed

P.48 掲載の参考文献

1) United States Renal Data System 2010 Annual Data Report. Am J Kidney Dis 57 (1) (suppl 1) : e1-e526, 2011

 

2) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日末現在), 透析会誌 46 (1) : 1-76, 2013

 

3) Yeares K, et al : Developing nephrology programs in very low-resource settings : challenges in sustainability. Kidney Int (suppl 3) : 202-205, 2013

 

4) 兵藤透, 山下明泰, 池田成江, 他 : アジア各国の透析状況調査とベトナム・カンボジア透析施設における透析液水質調査およびカンボジア血液浄化センター設立支援の経験から見た今後の発展途上国への透析支援に関する考察. 腎と透析73別冊HDF療法 '12 : 7-15, 2012

 

5) Zhi-Hong Liu : Nephrology in China. Nat Rev Nephrol 9 : 523-528, 2013

PubMed

P.54 掲載の参考文献

1) 八木澤隆, 三重野牧子, 湯沢賢治, 他 : 腎移植臨床統計からみた」腎移植の動向と成績. 日本臨床腎移植学会雑誌 1 : 159-165, 2013

 

2) 日本移植学会, 日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2013), 2012年実施症例の集計報告. 移植 48 : 346-361, 2013

Medical*Online

3) 日本臨床腎移植学会, 日本移植学会 : 腎移植臨床登録集計報告 (2010) -3, 2009年実施症例の集計報告 (3). 移植 45 : 608-620, 2010

 

4) 日本臨床腎移植学会, 日本移植学会 : 腎移植臨床登録集計報告 (2011) -2, 2010年実施症例の集計報告 (2). 移植 46 : 506-523, 2011

 

P.58 掲載の参考文献

1) Kong JM, Ahn J, Park JB, et al : ABO incompatible living donor kidney transplantation in Korea : highly uniform protocols and good medium-term outcome. Clin Transplant 27 : 875-81, 2013

PubMed

2) Zivcic-Cosic S, Busic M, Zupan Z, et al : Development of the Croatian model of organ donation and transplantation. Croat Med J 54 : 65-70, 2013

PubMed

3) WHO guiding principles on human cell, tissue and organ transplantation. As endorsed by the sixty-third World Health Assembly in May 2010, in Resolution WHA63.22

PubMed

4) Garcia GG, Harden P, Chapman J ; World Kidney Day Steering Committee 2012 : The global role of kidney transplantation. Nephrol Dial Transplant 28 : e1-5, 2013

 

5) 絵野沢伸 : ドナー数増加に向けた海外の取り組み. 移植 44 : s221-s224, 2009

 

6) International Summit on Transplant Tourism and Organ Trafficking : The Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Clin J Am Soc Nephrol 3 : 1227-1231, 2008

PubMed

腎代替療法の選択 ( 導入 )

P.63 掲載の参考文献

1) 岡田一義, 大平整爾, 伊丹儀友, 他 : 慢性血液透析路湯法の導入と終末期患者に対する見合わせに関する提言 (案). 透析会誌 45 : 1090-1095, 2012

 

2) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在). 透析会誌 47 (1) : 1-56, 2014

 

3) 小川洋史 : 在宅血液透析の形態 : 現況と課題. 人工臓器 39 : 68-71, 2010

 

4) 渡邊有三, 中本雅彦, 千葉栄市, 他 : 在宅 (家庭) 血液透析についての提言. 透析会誌 31 : 959-965, 1998

 

P.67 掲載の参考文献

1) Lee S, Ryu JH, Kim H, Kim KH, et al : An assessment of survival among Korean elderly patients initiating dialysis : a national population-based study. PLoS One 9 (1) : e86776, 2014

PubMed

2) de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM : Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20 (9) : 2075-2084, 2009

PubMed

3) Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torlen K, et al : Dialysis modality and correction of uremic metabolic acidosis : relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol 8 (2) : 254-264, 2013

PubMed

4) Chang TI, Oh HJ, Kang EW, Yoo TH, et al : A low serum bicarbonate concentration as a risk factor for mortality in peritoneal dialysis patients. PLoS One 8 (12) : e82912, 2013

PubMed

5) Viglino G, Neri L, Barbieri S : Incremental peritoneal dialysis : effects on the choice of dialysis modality, residual renal function and adequacy. Kidney Int suppl 108 : S52-55, 2008

PubMed

6) Yamamoto S, Kasai A, Shimada H : High peritoneal clearance of small molecules did not provide low serum beta2-microglobulin concentrations in peritoneal dialysis patients. Perit Dial Int 23 (suppl 2) : S34-36, 2003

PubMed

7) Huang WH, Hung CC, Yang CW, Huang JY : High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients. Ther Apher Dial 16 (4) : 361-367, 2012

PubMed

8) Paniagua R, Amato D, Vonesh E, Correa-Rotter R, et al : Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis : ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 (5) : 1307-1320, 2002

PubMed

9) Nakayama M : Fluid status and its management in Japanese peritoneal dialysis patients. Perit Dial Int 26 (2) : 144-149, 2006

PubMed

10) Nakayama M, Miyasaki M, Honda K, et al : Encapsulating Peritoneal Sclerosis in the Era of a Multi-Disciplinary Approach Based on Biocompatible Solutions : The Next-Pd Study. Perit Dial Int 2014 [Epub ahead of print]

 

11) 中山昌明, 林義満, 旭浩一 : 腹膜透析ガイドラインと透析導入基準. 透析会誌 44 (2) : 133-134, 2011

 

12) Chang JH, Sung JY, Ahn SY, Ko KP, et al : Hemodialysis leads to better survival in patients with diabetes or high comorbidity, compared to peritoneal dialysis. Tohoku J Exp Med 229 (4) : 271-277, 2013

PubMed

13) Lobbedez T, Touam M, Evans D, Ryckelynck JP, et al : Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF). Nephrol Dial Transplant 26 (7) : 2332-2339, 2011

PubMed

14) Bertoli SV, Musetti C, Ciurlino D, Basile C, et al : Peritoneal ultrafiltration in refractory heart failure : a cohort study. Perit Dial Int 34 (1) : 64-70, 2014

PubMed

15) NakayamaM, Nakano H : Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiol 55 (1) : 49-54, 2010

PubMed

16) 岡本貴, 森本聡, 森田龍, 万木孝, 他 : 血液透析間体重増加の著しい透析困難症に腹膜透析の併用が有効であった1例. 透析会誌 42 (4) : 333-337, 2009

 

17) 中川卓, 木村庄, 藤本圭, 渥美浩, 他 : 腹水を伴う肝硬変合併腎不全に腹膜透析を導入した2例-日本における報告例のまとめ-. 透析会誌 43 (1) : 93-98, 2010

 

P.74 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在). 透析会誌 46 (1) : 1-76, 2013

 

2) 日本移植学会 : 臓器移植ファクトブック 2012

 

3) 高橋公太 : 奔流 腎移植の歴史ABO血液型不適合腎移植への挑戦 わが国第1例目の腎移植の偉業を讃えて, 高橋公太編著, 日本医学館, 東京, 2013

 

4) 斎藤和英 : 先行的腎移植ガイドラインワーキンググループによる実態調査. 腎移植連絡協議会からの提言変貌する腎移植-ABO血液型不適合臓器移植患者の輸血ガイドラインと先行的腎移植, 高橋公太編, pp28-37, 日本医学館, 東京, 2012

 

5) 2011 UNOS annual data report

 

6) Danovitch GM : Evaluation of Adult Kidney Transplantation Candidates. Handbook of Kidney Transplantation, Fifth ed, Lippincott Williams & Wilkins, Philadelphia, 2010

 

P.79 掲載の参考文献

1) 服部元史 : 小児末期慢性腎不全診療の歩みと現況. 透析会誌 42 : 137-144, 2009

 

2) 服部元史, 佐古まゆみ, 金子徹治, 他 : 2006年-2011年末までの期間中に新規発生した20歳未満の小児末期腎不全患者の実態調査報告. 日児腎誌 26 : 330-340, 2013

 

3) 一般社団法人日本透析医学会 維持血液透析ガイドライン : 血液透析導入. 透析会誌 46 : 1107-1155, 2013

 

4) 岡田一義, 大平整爾, 伊丹儀友, 他 : 慢性血液透析療法の導入と終末期患者に対する見合わせに関する提言 (案). 透析会誌 45 : 1090-1095, 2012

 

5) 服部元史 : 先行的腎移植とIC, 登録, 実施時期 : 小児患者. 腎と透析 73 : 849-854, 2012

Medical*Online

P.83 掲載の参考文献

1) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

2) Rocco M, Soucie JM, Pastan S, McClellan WM : Peritoneal dialysis adequacy and risk of death. Kidney Int 58 : 446-457, 2000

PubMed

3) Matsuo N, Yokoyama K, Maruyama Y, et al : Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. Clin Nephrol 74 : 209-216, 2010

PubMed

4) Wolfe RA, Ashby VB, Milford EL, et al : Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 : 1725-1730, 1999

PubMed

P.88 掲載の参考文献

1) 日本急性血液浄化学会編 : 2. 急性血液浄化の原理. 日本急性血液浄化学会標準マニュアル, pp11-17, 医学図書出版, 東京, 2013

 

2) 日本集中治療医学会Sepsis Registry委員会 : 日本版敗血症診療ガイドラインThe Japanese Guidelines for the Management of Sepsis. 日集中医誌 20 : 124-173, 2013

 

3) 中田孝明 : 肝腎症候群におけるhigh flow dialysate continuous hemodiafiltration. 日本アフェレシス学会雑誌 26 : 315-322, 2007

 

4) Laleman W : Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10 : R108, 2006

PubMed

5) Ariceta G, et al ; European Paediatric Study Group for HUS : Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24 : 687-696, 2009

 

透析

P.94 掲載の参考文献

1) 峰島三千男 : 血液浄化の基礎 ふるい係数の定義. 臨牀透析 14 : 1499-1503, 1998

 

2) 峰島三千男 : 血液浄化の基礎 血液の限外濾過特性. 臨牀透析 14 : 1861-1864, 1998

 

3) 峰島三千男 : 血液浄化の基礎 限外濾過率と濾過係数. 臨牀透析 15 : 129-132, 1999

 

4) 板垣一郎 : PMMA (polymethylmethacrylate) 膜. わかりやすい透析工学-血液浄化療法の化学的基礎, 酒井清孝, 峰島三千男編, pp42-6, 南江堂, 東京, 2012

 

5) 辰口俊秀 : PAN (polyacrylonitrile) 膜. わかりやすい透析工学-血液浄化療法の化学的基礎, 酒井清孝, 峰島三千男編, pp73-7, 南江堂, 東京, 2012

 

P.98 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在). 透析会誌 46 (1) : 1-76, 2013

 

2) 日本アフェレシス学会 : 実践 アフェレシス技術マニュアル 2011. 日本アフェレシス学会雑誌 30 (3) : 189-387, 2011

 

3) 日本透析医学会 : 腹膜透析ガイドライン. 透析会誌 42 (4) : 285-315, 2009

 

4) 日本透析医学会 : 日本透析医学会透析医学用語集. 透析会誌 40 (12) : 957-1023, 2007

 

P.103 掲載の参考文献

1) Babb AL, Popovich PP, Christapher TG, et al : The genesis of the square meter hour hypothesis. ASAIO 17 : 81-91, 1971

 

2) Gejyo F, Yamada T, Odani S, et al : A new form of amyloid protein associated with chronic hemodialysis was identified as b2-microglobulin. Biochem Biophys Res Commun 129 : 701-706, 1985

 

3) 小岩文彦, 秋澤忠男 : 血液浄化膜と生体反応. 臨牀透析 11 : 1815-1822, 1995

 

4) 五十嵐一生, 佐野直人, 河崎雅暢, 芝本隆 : 製膜時のPVP 添加の有無が血液適合性に与える影響について. 腎と透析71別冊ハイパフォーマンスメンブレン '11 : 167-170, 2011

 

P.108 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2010年12月31日現在). 日本透析医学会, 2011

 

2) 峰島三千男 : 血液浄化効率に影響与える因子 (2) 血液流量, 透析液流量 (基礎). 血液浄化療法の指針-新しい方向性, 斎藤明他編, pp103-112, 日本メディカルセンター, 東京, 1977

 

3) 石森勇, 村上淳, 金子岩和, 峰島三千男, 他 : 内部濾過流量の経時変化, 圧力連続モニタリングによる臨床評価. 腎と透析63別冊HDF療法 '07, 195-197, 2007

 

4) 蜂鳥三千男 : ダイアライザの内部漉過を促進しすぎると危険? : 内部漉過促進型血液透析における至適促進条件の重要性. クリニカルエンジニアリング 18 (2) : 134-137, 2007

 

5) 川西秀樹, 他 : 血液浄化器 (中空糸型) の機能分類 2013. 透析会誌 46 (5) : 501-506, 2013

 

P.112 掲載の参考文献

1) 佐藤威, 斎藤明, 内藤秀宗, 他 : 報告各種の血液浄化法の機能と適応-血液浄化器の性能評価法と機能分類. 透析会誌 29 : 1231-1245, 1996

 

2) 川口良人, 斎藤明, 内藤秀宗, 他 : 血液浄化器の新たな機能分類-血液浄化法, 適応との対応. 透析会誌 32 : 1465-1469, 1999

 

3) 川西秀樹, 峰島三千男, 竹澤真吾, 他 : 新たな透析液水質基準と血液浄化器の機能分類. 透析会誌 38 : 149-154, 2005

 

4) 川西秀樹, 峰島三千男, 友雅司, 他 : 血液浄化器 (中空糸型) の機能分類 2013. 透析会誌 46 : 501-506, 2013

 

5) 川西秀樹, 峰島三千男, 平方秀樹, 秋澤忠男 : 血液浄化器の性能評価法 2012. 透析会誌 45 : 435-445, 2012

 

6) Bonomini M, Pavone B, Sirolli V, et al : Proteomics characterization of protein adsorption onto hemodialysis membranes. J Proteome Res 10 : 2666-2674, 2006

PubMed

7) 石田正夫 : エチレンビニルアルコール共重合体透析器の血液適合性. 細胞 37 : 30-34, 2005

 

8) 佐藤元美, 依馬弘忠, 森田弘之, 他 : 透析膜の微小循環系への影響とその解析. 腎と透析55 別冊ハイパフォーマンスメンブレン '03 : 183-186, 2003

 

9) Ito S, Suzuki C, Tsuji T : Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species. J Biomed Mater Res 77A : 294-303, 2006

 

10) Sirolli V, Ballone E, Diliberato L, et al : Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis : effect of different synthetic membranes. Int J Artif Organs 22 : 536-542, 1999

 

11) Sakai Y, Tsukamoto H, Fujii Y, et al : Formation of poly (methylmethacrylate) membranes utilizing stereocomplex phenomenon. Ultrafiltration Membranes and Applications, Cooper AR (ed), pp 99-107, Plenum Publishing, New York, 1980

 

12) 菅谷博之, 上野良之, 山田智子, 他 : ハイパフォーマンス・メンブレンの構造と機能. 腎と透析61別冊ハイパフォーマンスメンブレン '06 : 19-23, 2006

 

13) Kato A, Takita T, Furuhashi M, et al : Polymethylmethacrylate efficacy in reduction of renal itching in hemodialysis patients : Crossover study and role of tumor necrosis factor-a. Artif Organs 25 : 441-447, 2001

PubMed

14) Lin HH, Liu YL, Liu JH, et al : Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artif Organs 32 : 468-472, 2008

PubMed

15) Masakane I : High-quality dialysis : a lesson from the Japanese experience. Nephrol Dial Transplant Plus 3 (suppl 1) : i28-35, 2010

 

16) Usuda M, Shinzato T, Sezaki R, et al : New simultaneous HF and HD with no infusion fluid. Trans Am Soc Artif Intern Organs 28 : 24-27, 1982

PubMed

17) 江口圭, 池辺宗三人, 金野好恵, 他 : 新しいHDF療法 (間歇補液HDF : Intermittent infusion HDF) の考案とその臨床効果. 透析会誌 40 : 769-774, 2007

 

18) Mineshima M, Eguchi K : Development of intermittent infusion hemodiafiltration (I-HDF) using ultrapure dialysis fluid with an automated dialysis machine. Blood Purif 35 (suppl 1) : 55-58, 2013

 

P.115 掲載の参考文献

1) 平成12 年度厚生科学特別研究班 (主任研究者 : 平澤由平) : 透析医療事故防止のための標準的透析操作マニュアル, 2001

 

2) 平成16 年度厚生労働科学研究班 (主任研究者 : 山崎親雄) : 「透析医療事故 (透析装置および周辺機器の故障や操作ミス関連) の実態」及び「標準的透析用血液回路」に関する研究, 2005

 

3) 山家敏彦, 那須野修一, 村上淳, 佐藤宜伯, 他 : 透析用血液回路の標準化に関する報告書 2006. 日本臨床工学技士会会誌 26 (特別号) : 54-63, 2006

 

4) ISO8638 : 2010 Cardiovascular implants and artificial organs-Extracorporeal blood circuit for haemodialysers, haemodiafilters and haemofilters

 

P.120 掲載の参考文献

1) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析療法の現況. 2012年末の慢性透析患者に関する基礎集計, 2013

 

2) 日本腎臓学会 : エビデンスに基づくCKD診療ガイド 2013, 東京医学社, 東京, 2013

 

3) Ethier J, et al : Vascular access use and outcomes : an international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 23 : 3219-3226, 2008

PubMed

4) Nakai S, et al : Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 14 : 505-540, 2010

PubMed

5) Nissenson AR, et al : Handbook of Dialysis Therapy, Third ed, Saunders Elsevier, Philadelphia, 2008

 

6) KDOQI : 2006 Updates Clinical Practice Guidelines and Recommendations.

 

7) Wilson SM, et al : The IMPACT (Incident Management of Patients, Actions Centered on Treatment) Program : A Quality Improvement Approach for Caring for Patients Initiating Long-term Hemodialysis. Am J Kidney Dis 60 : 435-443, 2012

 

8) Wingard RL, et al : The "right" of passage : surviving the first year of dialysis. Clin J Am Soc Nephrol 4 (suppl 1) : 114-120, 2009

 

9) Joki N, Hase H, Nakamura R, et al : Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial transplant 12 : 718-723, 1997

PubMed

10) Mast EE, et al : A comprehensive immunization strategy to eliminate transmmission of hepatitis B virus infection in the United States : Recommendation of the Advisory Committee on Immunization Practices (ACIP) Part II : Immunization of adults. MMWR Recomm Rep 55 : 1-33, 2006

 

11) Kausz A, et al : The value of vaccination in chronic kidney diseas. Semin Dial 17 : 9-11, 2004

 

12) 藤井正満 : 透析医療における病診連携について. 治療 84 : 1557-1561, 2002

Medical*Online

P.123 掲載の参考文献

1) Group KAGW : KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int (suppl 2) : 1-138, 2012

 

2) Ostermann M, Dickie H, Barrett NA : Renal replacement therapy in critically ill patients with acute kidney injury-when to start. Nephrol Dial Transplant 27 : 2242-2248, 2012

PubMed

3) Bouman CSC, Oudemans-van Straaten HM, Tijssen JGP, et al : Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure : a prospective, randomized trial. Crit Care Med 30 : 2205-2211, 2002

PubMed

4) Karvellas CJ, Farhat MR, Sajjad I, et al : A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury : a systematic review and meta-analysis. Critical care 15 : R72, 2011

 

5) Gibney N, Hoste E, Burdmann EA, et al : Timing of initiation and discontinuation of renal replacement therapy in AKI : unanswered key questions. Clin J Am Soc Nephrol 3 : 876-880, 2008

PubMed

6) Uchino S, Bellomo R, Morimatsu H, et al : Discontinuation of continuous renal replacement therapy : a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37 : 2576-2582, 2009

PubMed

7) Frohlich S, Donnelly A, Solymos O, et al : Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy. J Crit Care 27 : 744. e1-e5, 2012

 

8) Rabindranath K, Adams J, Macleod AM, et al : Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev CD003773, 2007

PubMed

9) Schneider AG, Bellomo R, Bagshaw SM, et al : Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury : a systematic review and meta-analysis. Intensive Care Med 39 : 987-997, 2013

PubMed

10) Fieghen HE, Friedrich JO, Burns KE, et al : The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC nephrol 11 : 32, 2010

PubMed

11) Ronco C, Bellomo R, Homel P, et al : Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure : a prospective randomised trial. Lancet 356 : 26-30, 2000

PubMed

12) The VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, et al : Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359 : 7-20, 2008

PubMed

13) RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al : Intensity of continuous renalreplacement therapy in critically ill patients. N Engl J Med 361 : 1627-1638, 2009

 

14) Gallagher M, Cass A, Bellomo R, et al : Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care : Extended Followup of a Randomized Controlled Trial. PLoS medicine 11 : e1001601, 2014

PubMed

15) Uchino S, Toki N, Takeda K, et al : Validity of lowintensity continuous renal replacement therapy. Crit Care Med 41 : 2584-2591, 2013

PubMed

16) Jorres A, John S, Lewington A, et al : A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury : part 2 : renal replacement therapy. Nephrol Dial Transplant 28 : 2940-2945, 2013

PubMed

P.131 掲載の参考文献

1) 川口良人, 他 : 慢性透析療法の透析導入ガイドライン作成に関する研究. 平成3年度厚生科学研究腎不全医療研究事業研究報告書, 125-132, 1992

 

2) Beddhu S, Samore MH, Roberts MS, et al : Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol 14 : 1000-1005, 2003.

PubMed

3) 日本透析医学会 : 維持血液透析ガイドライン : 血液透析導入. 透析会誌 46 : 1107-1155, 2013

 

4) Matsuo S, Imai E, Horio M, et al : Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53 : 982-992, 2009

PubMed

5) Horio M, Imai E, Yasuda Y, et al : GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis 61 : 197-203, 2013

PubMed

6) Hemodialysis Adequacy 2006 Work Group : Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48 (suppl 1) : S2-S90, 2006

 

7) 日本腎臓学会 : CKD診療ガイド 2012. 2012.

Medical*Online

8) Nakamura S, Nakata H, Yoshihara F, et al : Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases. Circ J 71 : 511-516, 2007

PubMed

9) Yamagata K, Nakai S, Masakane I, et al : Ideal timing and predialysis nephrology care duration for dialysis initiation : from analysis of Japanese dialysis initiation survey. Ther Apher Dial 16 : 54-62, 2012

PubMed

10) 日本透析医学会 : 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 44 : 855-937, 2011

 

11) Clinical practice guidelines for vascular access. Am J Kidney Dis 48 (suppl 1) : S248-S273, 2006

 

12) 日本透析医学会 : わが国の慢性透析療法の現況 (2008年12月31日現在). 2009

 

13) Collins AJ, Foley R, Herzog C, et al : Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 51 (1 suppl 1) : S1-320, 2008

 

14) Levin A, Hemmelgarn B, Culleton B, et al : Guidelines for the management of chronic kidney disease. CMAJ 179 : 1154-1162, 2008

PubMed

15) European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association : Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 17 (suppl 7) : 7-15, 2002

 

16) Kelly J, Stanley M, Harris D : The CARI guidelines. Acceptance into dialysis guidelines. Nephrology (Carlton) 10 (suppl 4) : S46-60, 2005

 

17) Churchill DN : An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 30 : 899-906, 1997

PubMed

18) Susantitaphong P, Altamimi S, Ashkar M, et al : GFR at initiation of dialysis and mortality in CKD : a metaanalysis. Am J Kidney Dis 59 : 829-840, 2012

PubMed

19) Pan Y, Xu XD, Guo LL, et al : Association of early versus late initiation of dialysis with mortality : systematic review and meta-analysis. Nephron Clin Pract 120 : c121-c131, 2012

PubMed

20) Cooper BA, Branley P, Bulfone L, et al : A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363 : 609-619, 2010

PubMed

21) Harris A, Cooper BA, Li JJ, et al : Cost-effectiveness of initiating dialysis early : a randomized controlled trial. Am J Kidney Dis 57 : 707-715, 2011

 

22) Di Micco L, Torraca S, Pota A, et al : Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR-a study on safety, quality of life and economic impact. Nephrol Dial Transplant 24 : 3434-3440, 2009

 

23) Brunori G, Viola BF, Parrinello G, et al : Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly : a prospective randomized multicenter controlled study. Am J Kidney Dis 49 : 569-580, 2007

PubMed

24) Nakai S, Masakane I, Shigematsu T, et al : An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial 13 : 457-504, 2009

PubMed

25) Charlson ME, Pompei P, Ales KL, et al : A new method of classifying prognostic comorbidity in longitudinal studies : development and validation. J Chronic Dis 40 : 373-383, 1987

PubMed

26) Stevenson KB, Hannah EL, Lowder CA, et al : Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data : predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39 (3) : 549-555, 2002

PubMed

P.135 掲載の参考文献

1) 日本透析医学会 : 維持血液透析ガイドライン : 血液透析処方. 透析会誌 46 : 587-632, 2013

 

2) National Kidney Foundation : Clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 48 (suppl 1) : s12-s47, 2006

 

3) Tattersall J, Martin-Malo A, Pedrini L, et al : EBPG guideline on dialysis strategies. Nephrol Dial Transplant 22 (supple 2) : ii5-21, 2007

 

4) 秋葉隆, 川西秀樹, 峰島三千男, 他 : 透析液水質基準と血液浄化器性能評価基準 2008. 透析会誌 41 : 159-167, 2008

 

5) 川西秀樹, 峰島三千男, 友雅司, 他 : 血液浄化器 (中空糸型) の機能分類 2013. 透析会誌 46 : 501-506, 2013

 

P.139 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在). 2013

 

2) Pauly RP, Gill JS, Rose CL, et al : Survival among nocturnal home hemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 24 : 2915-2919, 2009

PubMed

3) 渡辺有三, 中本雅彦, 他 : 在宅 (家庭) 血液透析についての提言. 透析会誌 31 : 959-965 1998

 

4) Scribner BH, Oreopolus DG : The Hemodialysis Product (HDP) : A better index of dialysis adequacy than Kt/V. Dial Transplant 31 : 13-15, 2002

 

5) Cafazzo JA, Leonard K, Easty AC, et al : Pacientperceived barriers to the adoption of nocturnal home hemodialysis. Clin J Am Soc Nephrol 4 : 784-789, 2009

 

6) 嵯峨清喜 : HHD治療と患者の自己決定権. 臨牀透析 23 : 1449-1454, 2007

 

P.142 掲載の参考文献

1) Charra B, Laurent G, Chazot C, et al : Clinical assessment of dry weight. Nephrol Dial Transplant 11 (suppl 2) : 16-19, 1996

 

2) Chazot C, Laurent G, Charra B, et al : Malnutrition in long-term hemodialysis survivors. Nephrol Dial Transplant 16 : 61-69, 2001

PubMed

3) 金田浩, 西山敏郎, 金田史香, 他 : 長時間透析物語-主として食塩 (Na) と血圧および栄養の物語です-, 東京医学社, 東京, 2013

 

4) 越川昭三 : 輸液, 中外医学社, 東京, 1970

 

5) Pierratos A : Effect of therapy time and frequency on effective solute removal. Semin Dial 14 (4) : 284-288, 2001

PubMed

6) 武田英二, 増田真志, 山本浩範 : リンとリン酸の生体における役割. 腎と透析 69 (2) : 145-148, 2010

Medical*Online

P.146 掲載の参考文献

1) Tentori F, Zhang J, Li Y, et al : Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis : results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 27 : 4180-4188, 2012

 

2) Eknoyan G, Beck GJ, Cheung AK, et al : Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 : 2010-2019, 2002

PubMed

3) Scribner BH, Oreopoulos DG : The Hemodialysis Product (HDP) : A better index of dialysis adequacy than Kt/V. Dial Transplant 31 : 13-15, 2002

 

4) The FHN Trial Group : In-center hemodialysis six times per week versus three times per week. N Engl J Med 363 : 2287-2300, 2010

PubMed

5) Suri RS, Lindsay RM, Bieber BA, et al : A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int 83 : 300-307, 2013

PubMed

P.150 掲載の参考文献

1) Kawanishi H, Akiba T, Masakane I, et al : Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008. Ther Apher Dial 13 : 161-166, 2009

PubMed

2) 日本透析医学会統計調査委員会 : 図説わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

3) Lornoy W, Becaus I, Billiouw JM, Sierens L, et al : Online haemodiafiltration. Remarkable removal of β2-microglobulin. Long-term clinical observations Nephrol Dial Transplant 15 : 49-54, 2000

 

4) Wizemann V, Lotz C, Techert F, Uthoff S : On-line hemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15 (supple 1) : 43-48, 2000

 

5) Nakai S, Iseki K, Tabei K, et al : Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 38 (4 suppl 1) : S212-216, 2001

 

6) Locatelli F, Marcelli D, Conte F, Limido A, et al : Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int 55 : 286-293, 1999

PubMed

7) Panichi V, Rizza GM, Paoletti S, et al : Chronic inflammation and mortality in haemodialysis : effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 23 : 2337-2343, 2008

PubMed

8) Carracedo J, Merino A, Nogueras S, et al : Onlinehemodiafiltration reduces the proinflammatory CD14+ CD16+ monocyte-derived dendritic cells : A prospective, crossover study. J Am Soc Nephrol 17 : 2315-2321, 2006

 

9) Ramirez R, Carracedo J, Merino A, et al : Microinflammation induces endothelial damage in hemodialysispatients : The role of convective transport. Kidney Int 72 : 108-113, 2007

 

10) Locatelli F, Altieri P, Andrulli S, et al : Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 21 : 1798-1807, 2010

PubMed

11) Canaud B, Bragg-Gresham JL, Marshall MR, et al : Mortality risk for patients receiving hemodiafiltration versus hemodialysis : European results from the DOPPS. Kidney Int 69 : 2087-2093, 2006

PubMed

12) Vilar E, Fry AC, Wellsted D, Tattersall JE, et al : Longterm outcomes in online hemodiafiltration and highflux hemodialysis : a comparative analysis. Clin J Am Soc Nephrol 4 : 1944-1953, 2009

PubMed

13) Santoro A, Mancini E, Bolzani R, et al : The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure : a small randomized controlled trial. Am J Kidney Dis 52 : 507-518, 2008

 

14) Grooteman MP, van den Dorpel MA, Bots ML, et al : Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23 : 1087-1096, 2012

PubMed

15) Ok E, Asci G, Toz H, et al : Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis : results from the Turkish OL-HDF Study. Nephrol Dial Transplant 28 : 192-202, 2013

PubMed

16) Maduell F, Moreso F, Pons M, et al : High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24 : 487-497, 2013

PubMed

P.155 掲載の参考文献

1) 竹沢真吾, 酒井清孝 : 透析と限外濾過による物質輸送. 日本臨牀 43 (特別号) : 823-833, 1985

 

2) Gejyo F, Yamada T, Odani S, et al : A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 129 (3) : 701-706, 1985

PubMed

3) 日本透析医学会 : わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

P.158 掲載の参考文献

1) 日本医療機器学会編 : 医療現場における滅菌保証のガイドライン 2010

 

2) Tisler A, et al : The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant 18 : 2601-2605, 2003

 

3) Locatelli F, Altieri P, Andrulli S, et al : Hemofiltration and Hemodiafiltration Reduce Intradialytic Hypotension in ESRD. J Am Soc Nephrol 21 : 1798-1807, 2010

PubMed

P.162 掲載の参考文献

1) 小林快三, 柴田昌雄, 加藤克己, 中村伸也, 他 : 血液透析患者に対する新しい体液管理法 (Extra Corporeal Ultra filtration Method : ECUM) の開発と応用に関する研究. 日腎会誌 14 : 539-553, 1972

 

2) Usuda M, Shinzato T, Sezaki R, Kawanishi A, et al : New simultaneous HF and HD with no infusion fluid. Trans Am Soc Artif Intern Organs 28 : 24-27, 1982

PubMed

3) 三輪真幹 : push and pull HDFの基礎と臨床. 臨牀透析12別冊HDF療法 '96 12-17, 1996

 

4) Maeda K, Kobayakawa H, Fujita Y, Takai I, et al : Effectiveness of push/pull hemodiafiltration using large-pore membrane for shoulder joint pain in longterm dialysis patients. Artif Organs 14 : 321-327, 1990

PubMed

5) Tsuruta K, Andoh F, Kurahara I, Kaku T, et al : A simple method for clinical application of push/pull hemodiafiltration. Contrib Nephrol 108 : 71-78, 1994

PubMed

6) Shinzato T, Fujisawa K, Nakai S, Miwa M, et al : Newly developed economical and efficient push/pull hemodiafiltration. Contrib Nephrol 108 : 79-86, 1994

PubMed

7) Shinzato T, Miwa M,Kobayakawa H, Morita H, et al : Effectiveness of new push/pull hemodiafiltration for arthralgia in long-term hemodialysis patients. Contrib Nephrol 112 : 111-118, 1995

PubMed

8) 新里高弘 : Push/pull HDF. 腎と透析 65 (臨時増刊号) : 147-151, 2008

 

P.165 掲載の参考文献

1) Bone RC, Balk RA, Cerra FB, et al : Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American college of Chest Physician/Society of Critical Care Medicine. Chest 101 : 644-655, 1992

 

2) 織田成人, 貞広智仁, 奥怜子, 他 : SIRS/多臓器不全. 腎と透析 65 (増刊号) : 376-379, 2008

 

3) 松田兼一, 針井則一, 柳沢政彦, 他 : 急性腎障害 (AKI) -腎代替療法. 内科 110 : 419-422, 2012

 

4) Karvellas CJ, Farhat MR, Sajjad I, et al : A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury : a systematic review and meta-analysis. Crit Care 15 : 1-10, 2011

 

5) Ostermann M, Dickie H, Barrett NA : Renal replacement therapy in critically ill patients with acute kidney injury--when to start. Nephrol Dial Transplant 27 : 2242-2248, 2012

PubMed

6) Palevsky PM, Zhang JH, O'Connor TZ, et al : Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359 : 7-20, 2008

PubMed

7) Dellinger RP, Levy MM, Rhodes A, et al : Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock : 2012. Crit Care Med 41 : 580-637, 2013

PubMed

8) Schiffl H : The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients. Int Urol Nephrol 42 : 435-440, 2010

PubMed

9) Joannes-Boyau O, Honore PM, Perez P, et al : Highvolume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study) : a multicentre randomized controlled trial. Intensive Care Med 39 : 1535-1546, 2013

PubMed

10) Matsuda K, Moriguchi T, Harii N, et al : Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure. Transfus Apher Sci 40 : 49-53, 2009

 

11) Matsuda K, Moriguchi T, Harii N, et al : Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure. Contrib Nephrol 173 : 182-190, 2011

 

P.168 掲載の参考文献

1) Klein E : Evaluation of hemodialyzers and dialysis membrane. No. (NIH) 77-1294, DHEW Pub. 1977

 

2) 日本透析医学会統計調査委員会 : "VI 生命予後" わが国の慢性透析療法の現況 (2000年12月31日現在). pp508-509, 日本透析医学会, 東京, 2001

 

P.172 掲載の参考文献

1) Schindler R, Lonnemann G, Shaldon S, et al : Transcription, not synthesis of interleukin 1 and tumor necrosis factor by complement. Kidney Int 37 : 85-92, 1990

 

2) Miyata T, Sugiyama S, Saito A, et al : Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int 78 : S25-31, 2001

PubMed

3) Verresen L, Fink E, Lemke HD, et al : Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 45 : 1497-1503, 1994

PubMed

4) Yokoyama H, Kawaguchi T, Wada T, et al : Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in Japanese patients on chronic non-reuse hemodialysis : a prospective cohort study from the J-DOPPS II study. Nephron Clin Pract 109 : c100-c108, 2008

 

5) Krane V, Krieter DH, Olschewski M, et al : Dialyzer membrane characteristics and outcome of patients with type2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49 : 267-275, 2007

 

6) Piroddi M, Pilolli F, Aritomi M, et al : Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes : an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol 35 : 559-572, 2012

PubMed

7) Matsumura M, Sasaki H, Sekizuka K, et al : Improved management of intradialytic hypotension using vitamin E-bonded polysulfone membrane dialyzer. Int J Artif Organs 33 : 147-153, 2010

PubMed

P.175 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2003年12月31日現在). 日本透析医学会, 2004

 

2) 小林未央子, 田村孝子, 木全直樹 : 透析患者の合併症ケア 2012-診断とその対策凝固・線溶系異常. 腎と透析 72 (4) : 516-520 : 2012

 

P.180 掲載の参考文献

1) 伊達敏行, 東小野智, 名古屋竜司, 他 : 血液透析前後における血中Ca分画の変動に関する検討-アセテートフリー透析液とアセテート含有透析液の比較検討-. Nephrology Frontier (増刊号) : 71-74, 2008

 

2) 伊達敏行, 松崎美香, 東小野智, 他 : 無酢酸透析液 (カーボスター) の長期使用による異所性石灰化促進の可能性. 腎と骨代謝 24 : 316, 2011

 

3) 松浦有希子, 稲熊大城, 板脇大輔, 他 : 透析液カルシウム濃度3.0 mEq/Lから2.75 mEq/Lへの変更は血清PTH濃度に影響しない. 透析会誌 45 : 873-880, 2012

 

4) 川端雅彦, 春日修二, 小川哲也, 他 : 血液透析と血液濾過透析治療における循環血液量の経時的推移. 透析会誌 31 : 57-62, 1998

 

5) 日本血液浄化技術学会. http://www.jyouka.com/pdf/hojyueki2012.pdf

 

6) Malberti F, Corradi B, Tetta C, et al : Calcium balance and serum ionized calcium fluctuations in on-line haemodiafiltration in relation to ultrafiltration rate and dialysate calcium concentration. Nephrol Dial Transplant 9 : 1759-1764, 1994

 

P.184 掲載の参考文献

1) 山下芳久 : 透析装置の現状と未来. 臨牀透析 28 (6) : 7-12, 2012

 

2) 山下芳久 : 透析技術-透析装置の自動化とモニタリング-. 人工臓器 42 (3) : 221-225, 2013

 

3) 田岡正宏 : 透析装置 (各種自動化装置). 臨牀透析 29 (7) : 79-83, 2013

 

P.190 掲載の参考文献

1) 秋葉隆, 川西秀樹, 峰島三千男, 政金生人, 他 : 透析液水質基準と血液浄化器性能評価基準 2008. 透析会誌 41 : 159-167, 2008

 

2) 川西秀樹, 政金生人, 峰島三千男, 武本佳昭, 他 : 2011年版社団法人日本透析医学会「エンドトキシン捕捉フィルタ (ETRF) 管理基準」. 透析会誌 44 : 977-990, 2011

 

3) ANSI/AAMI RD52 : 2004. Dialysate for hemodialysis. AAMI, VA USA, 2004

 

4) The EBPG expert group on Hemodialysis : European best practice guidelines for hemodialysis (part 1), Section IV. Dialysis fluid purity. Nephrol Dial Transplant 17 (suppl 7) : 45-62, 2002

 

5) International Organization for Standardization : http://www.iso.org

 

P.194 掲載の参考文献

1) 石山陽事 (編) : クリニカルエンジニアリング 18 (1) : 2007

 

2) 加納隆, 深澤伸慈, 別所郁夫, 他 : フローチャートでみるナースのためのME機器トラブルチェック, 南江堂, 東京, 2005

 

3) 小電力医用テレメータの運用規定, (社) 電子情報技術産業協会, 2002

 

4) 小田順一, 横手卓也 : 6. 各種循環血液量モニタ. 臨牀透析 29 : 1061-1062, 2013

 

P.199 掲載の参考文献

1) 太田和夫 : 図説 ブラッドアクセス 作り方と使い方 (改訂第2版), 南江堂, 東京, 1999

 

2) 太田和夫 : 透析医療の歴史-先人達の軌跡をたどって, メディカ出版, 大阪, 2008

 

3) Pisoni RL, Arrington CJ, Albert JM, Ethier J, et al : Facility hemodialysis vascular access use and mortality in countries participating in DOPPS : An instrumental variable analysis. Am J Kidney Dis 53 (3) : 475-491, 2009

PubMed

4) 社団法人日本透析医学会 : 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 38 (9) : 1491-1551, 2005

 

5) 社団法人日本透析医学会 : 2011年版慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 44 : 855-937, 2011

 

6) 久木田和丘 : バスキュラーアクセスの作製・管理・修復-標準化をふまえた個別化 I 日本透析医学会2011年版バスキュラーアクセスガイドラインの作製趣旨と課題. 臨牀透析 30 (2) : 7-13, 2014

 

P.202 掲載の参考文献

1) 日本透析医学会日本透析医学会 : 2011年版「慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン」. 透析会誌 44 : 857-858, 2011

 

2) Brescia MJ, Cimino JE, Hurwich BJ : Chronic haemodialysis using vein puncture and a surgically created arteriovenous fistula. N Engl J Med 275 : 1089-1092, 1966

 

3) 久木田和丘, 増子佳弘, 有倉潤, 他 : タバチエール内シャントは内シャント寿命を延長するか. 腎と透析50別冊アクセス 2001 : 87-89, 2001

 

4) 久木田和丘, 川村明夫 : 人工血管の選択と新素材. 透析患者の合併症とその対策 17 : 41-47, 2008

 

P.206 掲載の参考文献

1) 日本透析医学会 : 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 44 (9) : 855-938, 2011

 

2) 日本透析医学会 : 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 38 (9) : 1491-1551, 2005

 

3) 村上譲, 萩原正大, 伊藤健太, 他 : 長期留置カテーテルへの細菌の定着が原因と考えられた腰椎化膿性脊椎炎の一例. 腎と透析69別冊アクセス 2010 : 108-110, 2010

 

4) 二宮秀平, 宮田昭, 若松志保, 他 : 皮下留置部分での長期型バスキュラーカテーテル破損の1例. 腎と透析65別冊アクセス 2008 : 95-97, 2008

 

5) 室谷典義 : 長期留置型カテーテルの使用状況と課題. 日透医誌 25 (3) : 502-506, 2010

 

P.209 掲載の参考文献

1) 中井滋, 鈴木一之, 政金生人, 他 : わが国の慢性透析療法の現況 (2008年12月31日現在). 透析会誌 43 : 1-35, 2009

 

2) 久木田和丘, 大平整爾, 天野泉, 他 : 2011年版慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 44 : 857-937, 2011

 

3) 室谷典義, 春口洋昭 : 第7章 動脈表在化 : 適応・手技・管理. バスキュラーアクセスその作製・維持・管理・修復の実際, 天野泉編, pp49-45, 中外医学社, 東京, 2007

 

4) 日本透析医学会 : 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 38 : 1491-1551 : 2005

 

5) 鎌田正, 朱星華, 落合美由希, 他 : 超音波ガイド下に大腿静脈反復穿刺を行い血液浄化法を施行した16例の検討. 透析会誌 45 : 241-246, 2012

 

6) Kaneda H, Kaneda F, Shimoyamada K, et al : Repeated femoral vein puncturing for maintenance hemodialysis vacular access. Nephrol Dialysis Transpant 18 : 1631-1638, 2003

 

P.213 掲載の参考文献

1) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

2) Van Biesen W, Vanholder R, Lameire N : The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 20 : 375-383, 2000

PubMed

3) Chaudhary K, Sangha H, Khanna R : Peritoneal dialysis first : Rationale, Clin J Am Soc Nephrol 6 : 447-456, 2011

PubMed

4) Covic A, Bammens B, Lobbedez T, et al : Educating end-stage renal disease patients on dialysis modality selection : a clinical advice from the European Renal Best Practice (ERBP) Advisory Board. NDT Plus 3 : 225-233, 2010

 

5) Li PKT, Culleton BF, Ariza A, et al : Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 24 : 1889-1900, 2013

PubMed

P.216 掲載の参考文献

1) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析療法の現況 (2012年12月31日現在). 2013

 

2) 日本透析医学会 : 2009年版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 (4) : 285-315, 2009

 

3) Nolph K : Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplantat 13 (suppl 6) : 117-119, 1998

 

4) Michels W : Quality of life in automated and continuous ambulatory peritoneal dialysis. Perit Dial Int 31 (2) : 138-147, 2011

PubMed

5) Dimkovic N : Assisted Peritoneal Dialysis : What is it and who does it involve? Adv Perit Dial 25 : 165-170, 2009

PubMed

P.218 掲載の参考文献

1) 中山昌明, 他 : CAPD療法の変遷とPD+HD併用療法. 日腎会誌 55 : 493-497, 2013

 

2) 丸山之雄, 他 : 課題と対策 (4) 併用療法-EARTH研究. 臨牀透析 28 (5) : 587-594, 2012

 

3) Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis, Japanese Society for Dialysis Therapy : 2009 Japanese Society for Dialysis Therapy guideline for peritoneal dialysis. Ther Apher Dial 14 : 489-504, 2010

 

4) 植田敦志, 他 : 併用 (HD+PD) 導入は残存腎機能と血清アルブミンを保持し, 生命予後を改善させる. 腎と透析75別冊腹膜透析 2013 : 159-160, 2013

 

5) Suzuki H et al : New modality of dialysis therapy : peritoneal dialysis first and transition to home hemodialysis. Adv Perit Dial 28 : 106-111, 2012

PubMed

6) 小板橋賢一郎, 他 : 無尿の血液透析患者に血液透析と腹膜透析の併用療法を導入しQOLが改善した1例. 腎と透析65別冊腹膜透析 2008 : 396-398, 2008

 

P.222 掲載の参考文献

1) Williams JD, Craig KJ, Topley N, et al : Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13 (2) : 470-479, 2002

PubMed

2) Topley N, Kaur D, Petersen MM, et al : Biocompatibility of bicarbonate buffered peritoneal dialysis fluids : influence on mesothelial cell and neutrophil function. Kidney Int 49 (5) : 1447-1456, 1996

PubMed

3) Nakao A, Nakao K, Takatori Y, et al : Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy. Nephrol Dial Transplant 25 (5) : 1479-1488, 2010

PubMed

4) Takatori Y, Akagi S, Nakao K, et al : Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management : a randomized controlled trial. Clin J Am Soc Nephrol 6 (6) : 1337-1344, 2011

PubMed

5) Ogata S, Naito T, Yorioka N, et al : Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor. Nephrol Dial Transplant 19 (11) : 2831-2837, 2004

 

P.226 掲載の参考文献

1) Moncrief JW, Popovich RP, Broadrick LJ, et al : The Moncrief-Popovich catheter : a new peritoneal access technique for patients on peritoneal dialysis. ASAIO J 39 : 62-65, 1993

PubMed

2) Danielsson A, Blohme L, Tranaeus A, et al : A prospective randomized study of the effect of a subcutaneouslyeburiediperitoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection. Perit Dial Int 22 : 211-219, 2002

PubMed

3) Strippoli GF, Tong A, Johnson D, et al : Catheterrelated interventions to prevent peritonitis in peritoneal dialysis : a systematic review of randomized, controlled trials. J Am Soc Nephrol 15 : 2735-2746, 2004

PubMed

P.229 掲載の参考文献

1) Miller JH, Gipstein R, Margules R, Schwartz M, et al : Automated peritoneal dialysis : analysis of several methods of peritoneal dialysis. Trans Am Soc Artif Intern Organs 12 : 98-105, 1966

PubMed

2) Yamashita A, Ishizaki M, Nakamoto M, Kawanishi H, et al : Re-evaluation of adequate dose in Japanese PD patients. Adv Perit Dial 19 : 254-258, 2003

 

P.234 掲載の参考文献

1) Jorres A : Novel Peritoneal Dialysis Solutions-What Are the Clinical Implications? Blood Purif 33 : 153-159, 2012

PubMed

2) Qi H, Xu C, Yan H, Ma J : Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis : a meta-analysis of randomized controlled trials. Perit Dial Int 31 : 179-188, Review, 2011

 

3) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析患者の現況 (2012年12月31日現在). (図表 31), pp33, 2013

 

4) Tsuchida K, Takemoto Y, Nakamura T, Yamagami S : Unexpected complication resulting from peritoneal dialysis catheter break. Perit Dial Int 18 : 444-445, 1998

PubMed

P.237 掲載の参考文献

1) Okada S, Midorikawa O : Induction of rat renal adenocarcinoma by Fe-nitrlotriacetate (Fe-NTA). Jpn Arch Intern Med 29 : 485-491, 1982

 

2) 倉賀野隆裕, 中西健 : 人工透析における鉄代謝管理. 日内会誌 99 (6) : 1226-1232, 2010

 

3) Joosten LA, Netea MG, Mylona E, et al : Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1b production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystalinduced gouty arthritis. Arthritis Rheum 62 (11) : 3237-3248, 2010 doi : 10.1002/art.27667

 

4) Correa-Costa M, Braga TT, Semedo P, et al : Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS One 6 (12) : e29004, 2011

PubMed

P.241 掲載の参考文献

1) Eknoyan G, Beck GJ, Cheung AK, et al : Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 : 2010-2019, 2002

PubMed

2) Cheung AK, Rocco MV, Yan G, et al : Serum beta-2 microglobulin levels predict mortality in dialysis patients : results of the HEMO study. J Am Soc Nephrol 17 : 546-555, 2006

PubMed

3) 石井恵理子, 安藤康宏, 草野英二, 他 : 血液透析 (HD) 患者の血中心房性ナトリウム利尿ペプチド (ANP) 値によるドライウエイト (DW) の判断基準に関する検討. 透析会誌 37 : 1417-1422, 2004

 

4) Minuk GY, Sun DF, Greenberg R, et al : Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40 : 1072-1077, 2004

 

5) Rocco MV, Jordan JR, Burkart JM : Changes in peritoneal transport during the first month of peritoneal dialysis. Perit Dial Int 15 : 12-17, 1995

PubMed

P.246 掲載の参考文献

1) 日本透析医会 : 安定期慢性維持透析の保険診療マニュアル. 日透医誌 5 (3) : 195-199, 1989

 

2) 日本透析医学会 : 慢性腎臓病における腎性貧血治療のガイドライン. 透析会誌 41 (10) : 661-716, 2008

 

3) 日本透析医学会 : 維持血液透析ガイドライン : 血液透析処方. 透析会誌 46 (7) : 587-632, 2013

 

4) 日本透析医学会 : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 透析会誌 45 (4) : 301-356, 2012

 

5) 日本透析医学会 : 血液透析患者における心血管系合併症の評価と治療に関するガイドライン. 透析会誌 44 (5) : 337-425, 2011

 

6) 日本透析医学会 : 血液透析患者の糖尿病治療ガイド 2012. 透析会誌 46 (3) : 311-357, 2013

 

7) 日本透析医学会 : 透析患者のC型ウイルス肝炎治療ガイドライン. 透析会誌 44 : 481-531, 2011

 

P.250 掲載の参考文献

1) 中山昌明, 川西秀樹, 友雅司, 他 ; 日本透析医学会腹膜透析療法ガイドライン作成ワーキンググループ : 2009年版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 (4) : 285-315, 2009

 

2) National Kidney Foundation : NKF-DOQI clinical practice guideline for peritoneal adequacy. Am J Kidney Dis 30 (suppl 2) : S67-136, 1997

 

3) Peritoneal Dialysis Adequacy Work Group : Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 48 (suppl 1) : S91-129, 2006

 

4) Yokoyama K, Yoshida H, Matsuo N, Maruyama Y, et al : Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients. Clin Nephrol 69 (2) : 121-126, 2008

PubMed

5) Matsuo N, Yokoyama K, Maruyama Y, et al : Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. Clin Nephrol 74 : 209-216, 2010

PubMed

P.253 掲載の参考文献

1) 服部元史, 佐古まゆみ, 金子徹治, 他 : 2006年-2011年末までの期間中に新規発症した20歳未満の小児末期腎不全患者の実態調査報告. 日本小児腎臓病学会雑誌 26 : 330-340, 2013

 

2) 木村健二郎, 岡田浩一, エビデンスに基づくCKD診療ガイドライン 2013作成委員会, 他 : エビデンスに基づくCKD診療ガイドライン 2013. 日腎会誌 55 : 585-860, 2013

 

3) 和田尚弘 : 本邦小児PDの現況 2007. 小児PD研究会雑誌 21 : 47-49, 2009

 

4) 和田尚弘 : 本邦小児PDの現況 2007 (第2報). 小児PD研究会雑誌 22 : 37-39, 2010

 

5) 東京都立小児総合医療センター腎臓内科編 : PD (腹膜透析). 小児のCKD/AKI 実践マニュアル-透析・移植まで-, 本田雅敬, 幡谷浩史, 石倉健司監修, pp19-72, 診断と治療社, 東京, 2013

 

6) Honda M, Shishido S : Recent Developments in the Management of Infants with End-Stage Renal Disease. Clin Exp Nephrol 2 : 1-11, 1998

 

7) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents : The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatr 114 : 555-576, 2004

 

P.256 掲載の参考文献

1) 服部元史, 松永明, 五十嵐徹, 他 : 1998年-2005年末までの期間発生した15歳未満の末期腎不全症例の2007年末の状態に関する追跡調査 : 集計結果の報告. 日児腎誌 22 : 226-228, 2009

 

2) 服部元史, 佐古まゆみ, 金子徹治, 他 : 2006年-2011年までの期間中に新規発生した20歳未満の小児末期腎不全患者の実態調査報告. 日児腎誌 26 : 330-340, 2013

 

3) 伊丹儀友 : 血液透析. 小児腎臓病学, 日本小児腎臓病学会編, pp434-438, 診断と治療社, 東京, 2012

 

P.260 掲載の参考文献

1) 中倉兵庫, 芦田明, 服部元史 : 17. 小児腹膜透析の特性. 知っておきたい腹膜透析実践マニュアル, 内藤秀宗, 大平整爾編, 診断と治療社, 東京, 2010

 

2) Vascular Access Work Group : Clinical practice guidelines for vascular access. Am J kidney Dis 48 : S248-273, 2006

PubMed

3) 相馬泉, 中倉兵庫, 服部元史 : 5. 小児透析関連機器 (PDとHD). 腎と透析 70 (増刊号) : 203-207, 2011

 

4) 2011年版社団法人日本透析医学会 : 「慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン」. 透析会誌 44 : 855-937, 2011

 

5) 古山政幸, 相馬泉, 水谷誠, 他 : 小児における長期留置型バスキュラーアクセスの挿入・固定に関する検討. 日本小児腎臓病学会誌 23 : 119-122, 2010

 

6) 2005年版社団法人日本透析医学会 : 「慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン」. 透析会誌 38 : 1491-1551, 2005

 

7) 相馬泉, 服部元史 : VA 作製の実際と術直後の管理 (5) 小児に対するVA. 臨牀透析27 : 839-848, 2011

 

P.264 掲載の参考文献

1) http://www.linkclub.or.jp/~pedpdjpn/PDMan100.pdf

 

2) 東京都立小児総合医療センター腎臓内科編 : 小児のCKD/AKI実践マニュアル-透析・移植まで-, 診断と治療社, 東京, 2013

 

3) 内藤秀宗, 大平整爾編 : 知っておきたい腹膜透析実践マニュアル, 診断と治療社, 東京, 2010

 

4) 特定非営利活動法人日本急性血液浄化学会編 : 日本急性血液浄化学会標準マニュアル, 医学図書出版, 東京 2013

 

P.270 掲載の参考文献

1) 日本小児PD・HD研究会 : 小児PD治療マニュアル, 2005 http://www.linkclub.or.jp/~pedpdjpn/

 

2) Mitsnefes MM : Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23 : 578-85, 2012

PubMed

3) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents : The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 : 555-76, 2004

 

4) 日本透析医学会 : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 透析会誌 45 : 301-356, 2012

 

5) 日本透析医学会 : 2008年版慢性腎臓病患者における腎性貧血治療のガイドライン. 透析会誌 41 : 661-716, 2008

 

6) Hattori M, Uemura O, Hataya H, et al : Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease : a multicenter prospective study in Japan. Clin Exp Nephrol 2013 Sep 7. [Epub ahead of print]

 

7) 服部元史 : 小児慢性腎不全患者の成長. 今日の移植 20 : 341-348, 2007

Medical*Online

8) Elzouki A, Carroll J, Butinar D, et al : Improved neurological outcome in children with chronic renal disease from infancy. Pediatr Nephrol 8 : 205-210, 1994

PubMed

9) Qvist E, Pihko H, Fagerudd P, et al : Neurodevelopmental outcome in high-risk patients after renal transplantation in early childhood. Pediatr Transplant 6 : 53-62, 2002

PubMed

P.274 掲載の参考文献

1) 厚生労働省策定 : 日本人の食事摂取基準 (2010年版), 第一出版, 東京, 2009

 

2) 日本透析医学会 : 2009年度版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 (4) : 285-315, 2009

 

3) 飯塚美和子, 他 : 最新子どもの食と栄養, p121, 学建書院, 東京, 2014

 

4) 文部科学省科学技術・学術審議会 : 資源調査分科会報告日本食品標準成分表 2010

 

P.277 掲載の参考文献

1) 沼澤理絵, 中尾康夫 : 透析患者の術前水分管理と麻酔下における心機能測定. 循環制御 23 : 416-419, 2002

Medical*Online

2) 中尾康夫 : 周術期における透析患者に対する麻酔法. 臨牀透析 19 : 773-778, 2003

 

3) 沼澤理絵, 中尾康夫, 久木田和丘, 他 : 透析患者998症例における麻酔関連危機的偶発症. 透析会誌 40 : 351-359, 2007

 

4) 久木田和丘, 中尾康夫, 後藤順一, 他 : 慢性透析患者の周術期管理. ICUとCCU 26 : s19-s20, 2002

 

5) 久木田和丘, 堀江卓, 米川元樹, 他 : 消化器手術における透析患者の周術期管理と血液浄化. Clin Eng 15 : 1009-1013, 2004

 

P.280 掲載の参考文献

1) Valtin H : Disorders of K+ balance. Renal dysfunction, pp89-111, Little, Brown and Company, Boston, 1979

 

2) 高市憲明 : 透析トラブルQ&A カリウム異常の原因と対策について教えてください. 腎と透析 64 : 687-690, 2008

 

3) ヒース雪, 小松康宏 : 透析液と置換液. 腎と透析 74 (増刊号) : 867-872, 2013

 

4) 寺脇博之, 中山昌明 : CAPD透析液. 腎と透析 74 (増刊号) : 873-876, 2013

 

5) Sullivan C, Sayre SS, Leon JB, Machekano R, et al : Effect of food additives on hyperphosphatemia among patients with end-stage renal disease : a randomized controlled trial. JAMA 301 (6) : 629, 2009

PubMed

P.284 掲載の参考文献

1) Agarwal R : The controversies of diagnosing and treating hypertension among hemodialysis patients. Semin Dial 25 (4) : 370-376, 2012

PubMed

2) Kooman JP, van der Sande FM, Leunissen KM : Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif 22 (1) : 55-59, 2004

PubMed

3) Odudu A, McIntyre C : Volume is not the only key to hypertension control in dialysis patients. Nephron Clin Pract 120 (3) : c173-177, 2012

 

4) Agarwal R, Sinha AD : Cardiovascular protection with antihypertensive drugs in dialysis patients : systematic review and meta-analysis. Hypertension 53 (5) : 860-866, 2009

PubMed

5) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (An overview of regular dialysis treatment in Japan), 2001

 

P.288 掲載の参考文献

1) 社団法人日本透析医学会 : 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 44 (5) : 337-425, 2011

 

2) Shoji T, Tsubakihara Y, Fujii M, et al : Hemodialysisassociated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66 : 1212-1220, 2004

PubMed

3) Joki N, Hase H, Nakamura R, et al : Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 12 (4) : 718-723, 1997

PubMed

4) 日本透析医学会 : わが国の慢性透析療法の現況1999年末現在. pp973-997, 日本透析医学会, 2000

 

5) Selby NM, McIntyre CW : A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 21 (7) : 1883-1898, 2006

PubMed

P.291 掲載の参考文献

1) Patel N, Dalal P, Paneser M : Dialysis disequilibrium syndrome：a narrative review. Semin Dial 21 (5) : 493-498, 2008

 

2) Kennedy AC, Linton AL, Eaton JC : Urea levels in cerebrospinal fluid after hemodialysis. Lancet 1 : 410-411, 1962

PubMed

3) Ariefff AI : Dialysis disequilibrium syndrome : Current concepts on pathogenesis and prevention. Kidney Int 45 : 629-635, 1994

 

4) Chen CL, Lai PH, Chou KJ, et al : A preliminary report of brain edema in patients with uremia at first hemodialysis : evaluation by diffusion-weighted MR imaging. AJNR Am J Neuroradiol 28(1)：68-71, 2007

PubMed

5) Mailloux LU：Dialysis disequiliburium syndrome. Up to Date, 2014

 

6) 渡邊紳一郎, 副島一晃, 町田二郎, 他 : 脳出血を生じた慢性透析患者の急性期管理および予後の検討. ICUとCCU 26 : S273-275, 2002

Medical*Online

P.296 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在). 2013 http://docs.jsdt.or.jp/overview/index.html

 

2) 日本透析医学会 : 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 44 (5) : 337-425, 2011

 

3) 合同研究班 : 急性心不全治療ガイドライン (2011年改訂版) (2014年3月10日日本循環器学会HP閲覧, 最新情報はhttp://www.j-circ.or.jp/guideline/をご確認ください)

 

4) 合同研究班 : 慢性心不全治療ガイドライン (2010年改訂版) (2014年3月10日日本循環器学会HP閲覧, 最新情報はhttp://www.j-circ.or.jp/guideline/をご確認ください)

 

5) 石井恵理子, 他 : 血液透析 (HD) 患者の血中心房性ナトリウム利尿ペプチド (ANP) 値によるドライウェイト (DW) の判断基準に関する検討. 透析会誌 37 (6) : 1417-1422, 2004

 

P.300 掲載の参考文献

1) 伊東春樹 : 合併症と至適透析 不整脈 : 至適透析をめざして, 太田和夫監修, pp143-157, 中外医学社, 東京, 1995

 

2) 日本循環器学会他7学会合同研究班 : 不整脈の非薬物治療ガイドライン (2011年改訂版) 循環器病の診断と治療に関するガイドライン, 2011 http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf

 

3) Genovesi S, Pogliani D, Faini A, et al : Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46 : 897-902, 2005

 

4) 日本透析医学会 : 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 44 : 337-425, 2011

 

5) Cuculich PS, Sanchez JM, Kerzner R, et al : Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30 : 207-213, 2007

PubMed

P.303 掲載の参考文献

1) Moroi M, Tamaki N, Nishimura M, et al : Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis : results from a cohort study in Japan. Am J Kidney Dis 61 : 466-475, 2013

PubMed

2) Middleton RJ, Parfrey PS, Foley RN : Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12 : 1079-1084, 2001

 

3) Shinohara K, Shoji T, Tsujimoto Y et al : Arterial stiffness in predialysis patients with uremia. Kidney Int 65 : 936-943, 2004

PubMed

4) 日本透析医学会 : 図説わが国の慢性透析療法の現況, http://docs.or.jp

 

5) Shroff GR, Frederick PD, Herzog CA : Renal failure and acute myocardial infarction : clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J 163 : 399-406, 2012

 

P.308 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

2) K/DOQI Workgroup K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 : S1-153, 2005

PubMed

3) 篠原幸人, 小川彰, 鈴木則宏, 他編 : 脳卒中治療ガイドライン 2009, 協和企画, 東京, 2009

 

4) 日本透析医学会学術委員会「血液透析患者の心血管合併症の評価と治療に関するガイドライン」作成委員会編 : 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 44 : 337-425, 2011

 

5) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Group : KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int (suppl 2) : 1-138, 2012

 

6) Yoshimitsu T, Hirakata H, Fujii K, et al : Cerebral ischemia as a causative mechanism for rapid progression of brain atrophy in chronic hemodialysis patients. Clin Nephrol 53 : 445-451, 2000

PubMed

7) 平方秀樹, 井関邦敏, 井林雪郎, 他 : 透析患者の脳血管障害に関する研究. 平成8年度厚生科学研究費補助金, 長期慢性疾患総合研究事業 (慢性腎不全) 研究報告集, pp49-54, 1997

 

8) Iseki K, Fukiyama K, The Okinawa Dialysis Study (OKIDS) Group : Clinical demographics and longterm prognosis after stroke in patients on chronic haemodialysis. Nephrol Dial Transplant 15 : 1808-1813, 2000

PubMed

9) 藤島正敏 : 日本人の脳血管障害. 日内会誌 55 : 39-50, 1996

 

10) Iseki K, Kinjo K, Kimura Y, et al : Evidence for high risk of cerebral hemorrhage in chronic hemodialysis patients. Kidney Int 44 : 1086-1090, 1993

PubMed

11) Iseki K, Miyasato F, Tokuyama K, et al : Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51 : 1212-1217, 1997

 

12) Toyoda K, Fujii K, Fujimi S, et al : Stroke in patients on maintenance hemodialysis : a 22-year single-center study. Am J Kidney Dis 45 : 1058-1066, 2005

PubMed

13) Becker KJ, Baxter AB, Bybee HM, et al : Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 30 : 2025-2032, 1999

PubMed

14) Fujii Y, Tanaka R, Takeuchi S, et al : Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80 : 51-57, 1994

PubMed

15) Mayer SA, Lignelli A, Fink ME, et al : Perilesional blood flow and edema formation in acute intracerebral hemorrhage : a SPECT study. Stroke 29 : 1791-1798, 1998

PubMed

16) Watanabe A : Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 16 : 30-33, 2007

PubMed

17) Imaizumi T, Horita Y, Hashimoto Y, et al : Dotlike hemosiderin spots on T2★-weighted magnetic resonance imaging as a predictor of stroke recurrence : a prospective study. J Neurosurg 101 : 915-920, 2004

 

18) Hudetz AG, Conger KA, Eke A, et al : A mathematical model of the intracerebral steal phenomenon in regional and focal ischaemia. Neurol Res 15 : 117-127, 1993

 

P.312 掲載の参考文献

1) 日本透析医学会 : わが国の慢性透析療法の現況 (2005年12月31日現在), 2006

 

2) Jaar BG, Astor BC, Berns JS, et al : Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients. Kidney Int 65 : 613-620, 2004

PubMed

3) Koch M, Trapp R, Kulas W, et al : Critical limb ischemia as a main cause of death in patients with end-stage renal disease : a single-centre study. Nephrol Dial Transplant 19 : 2547-2552, 2004

 

4) Aulivola B, Hile CN, Hamdan AD, et al : Major lower extremity amputation. Arch Surg 139 : 395-399, 2004

PubMed

5) O'Hare AM, Vittinghoff E, Hsia J, et al : Renal insufficiency and the risk of lower extremity peripheral arterial disease : Results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 15 : 1046-1051, 2004

 

6) Okamoto T, Oka M, Maesato K, et al : Peripheral arterial occlusive disease is more prevalent in patients with hemodialysis : Comparison with the findings of multidetector-row computed tomography. Am J Kidney Dis 48 : 269-276, 2006

 

7) 岡本好司, 岡真知子, 真栄里恭子, 他 : 透析患者における下肢閉塞性動脈硬化症-無侵襲診断法について-. 脈管学 46 : 829-835, 2006

 

8) Fishbane S, Youn S, Flaster E, et al : Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 27 : 668-672, 1996

PubMed

9) Al Zahrani HA, Al Bar HMS, Bahnassi A, et al : The distribution of peripheral artery disease in a defined population of elderly high-risk Saudi Patients. Int Angiol 16 : 123-128, 1997

 

10) Ono K, Yano S, Nojima Y : Ankle-arm blood pressure index as a marker of atherosclerosis in hemodialysis patients. (abstract) J Am Soc Nephrol 11 : A1535, 2000

 

11) Testa A, Ottavioli JN : Ankle-arm blood pressure index (AABPI) in hemodialysis patients. Arch Mal Coeur Vaiss 91 : 963-965, 1998

PubMed

12) Castronuovo JJ Jr, Adera HM, Smiell JM, et al : Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg 26 : 629-637, 1997

PubMed

13) K/DOQI Workgroup : K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (4 suppl 3) : S1-S153, 2005

 

14) Agishi T, Nakasato S, Ota K : Prognosis of patients with arteriosclerosis obliterans treated with LDL-apheresis. Vasc Surg 28 : 513-517, 1994

 

15) Kobayashi S, Moriya H, Negishi K, et al : LDL-apheresis up-regulates VEGF and IGF-1 in patients with ischemic limb. J Clin Apheresis 18 : 115-119, 2003

 

16) Kobayashi S, Moriya S, Maesato K, et al : LDL-apheresis improves peripheral artery occlusive disease with an implication for anti-inflammatory effects. J Clin Apheresis 20 : 239-243, 2005

 

17) Miyamoto M, Yasutake M, Takano H, et al : Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral artery disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 13 : 429-437, 2004

PubMed

18) Kawamura A, Horie T, Tsuda I, et al : Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial 9 : 59-63, 2005

PubMed

19) Baele HR, Piotrowski JJ, Yuhas J, et al : Infrainguinal bypass in patients with end-stage renal disease. Surgery 117 : 319-324, 1995

PubMed

20) Johnson BL, Glickman MH, Bandyk DF, et al : Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg 22 : 280-286, 1995

PubMed

21) Simsir SA, Cabellon A, Kohlman-Trigoboff D, et al : Factors influencing limb salvage and survival after amputation and revascularization in patients with end-stage renal disease. Am J Surg 170 : 113-117, 1995

PubMed

22) Leers SA, Reifsnyder T, Delmonte R, et al : Realistic expectations for pedal bypass grafts in patients with end-stage renal disease. J Vasc Surg 28 : 976-980, 1998

PubMed

23) Harpavat M, Gahtan V, Ierardi R, et al : Does renal failure influence infrainguinal bypass graft outcome? Am Surg 64 : 155-159, 1998

PubMed

24) Brosi P, Baumgartner I, Silvestro A, et al : Below-theknee angioplasty in patients with end-stage renal failure. J Endovasc Ther 12 : 704-713, 2005

 

25) Aulivola B, Garguilo M, Bessoni M, et al : Infrapopliteal angioplasty for limb salvage in the setting of renal failure : Do results justify its use? Ann Vasc Surg 19 : 762-768, 2005

 

26) Graziani L, Silvestro A, Bertone V, et al : Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 22 : 1144-1149, 2007

PubMed

27) Bergan JJ, Wilson SE, Wolf G, et al : Unexpected, late cardiovascular effects of surgery for peripheral artery disease. Arch Surg 127 : 1119-1123, 1992

PubMed

28) Dawson DL, Cutler BS, Meissner MH, Stranness DE Jr : Cilostazol has beneficial effects in treatment of intermittent claudication : results from a multicenter, randomized, prospective, double-blind trial. Circulation 98 : 678-686, 1998

 

29) Money SR, Herd JA, Isaacsohn JL, et al : Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 27 : 267-274, 1998

PubMed

30) Beebe HG, Dawson DL, Cutler BS, et al : A new pharmacological treatment for intermittent claudication : results of a randomoized, multicenter trial. Arch Intern Med 159 : 2041-2050, 1999

PubMed

31) Ohtake T, Sato M, Nakazawa R, et al : Randomized pilot trial between prostaglandin I2 analogue and antiplatelet drug on peripheral arterial disease in hemodialysis patients. Ther Apher Dial 18 (1) : 1-8, 2014

PubMed

32) Hidaka S, Kobayashi S, Iwagami M, et al : Sarpogrelate hydrochloride, a selective 5-HT (2A) receptor antagonist, improves skin perfusion pressure of the lower extremities in hemodialysis patients with peripheral arterial disease. Ren Fail 35 (1) : 43-48, 2013

PubMed

P.316 掲載の参考文献

1) 堀川直史, 志賀浪貴文, 佐藤聖子 : 認知症 (透析療法up-date). 腎と透析 74 : 999-1004, 2013

 

2) Kurella Tamura M, Yaffe K : Dementia and cognitive impairment in ESRD : diagnostic and therapeutic strategies. Kidney Int 79 : 14-22, 2011

PubMed

3) Sink KM, Holden KF, Yaffe K : Pharmacological treatent of neuropsychiatric symptoms of dementia : a review of the evidence. JAMA 293 : 596-608, 2005

 

4) 堀川直史 : 向精神薬の至適投与. 腎と透析 74 : 415-420, 2013

Medical*Online

5) Brodaty H, Arasaratnam C : Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry 169 : 946-953, 2012

PubMed

6) Ayalon L, Gum AM, Feliciano L, et al : Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia : a systematic review. Arch InternMed 166 : 2182-2188, 2006

PubMed

P.319 掲載の参考文献

1) Seifter JL, Samuels MA : Neurologic complication of chronic kidney disease. Comprehensive Nephrology 4th ed, pp985-986, Elsevier Inc, Missouri, 2010

 

2) Kumar G, Goyal MK : Lentiform Fork sign : a unique MRI picture. Is metabolic acidosis responsible? Clin Neurol Neurosurg 112 : 805-812, 2010

PubMed

3) Kang YJ, Bae EJ, Seo JW, et al : Two additional cases of metformin-associated encephalopathy in patients with end-stage renal disease undergoing hemodialysis. Hemodial Int 17 : 111-115, 2011

 

4) Fabiani G, Teive HA, Munhoz RP : Lentiform fork sign and fluctuating, reversible parkinsonism in a patient with uremic encephalopathy. Mov Disord 28 : 1053, 2012

 

5) Lee SH, Shin JA, Kim JH, et al : Chorea-ballism associated with nonketotic hyperglycaemia or diabetic ketoacidosis : Characteristics of 25 patients in Korea. Diabetes Res Clin Pract 95 : e80-83, 2011

 

6) Shaw C, Haas L, Miller D, et al : A case report of paroxysmal dystonic choreoathetosis due to hypoglycemia induced by an insulinoma. J Neurol Neurosurg Psychiatry 61 : 194-195, 1996

 

7) Sprague SM, Corwin HL, Tanner CM, et al : Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.Arch Intern Med 148 : 2169-2172, 1978

 

8) Ong AM, Tan CS, Foo MW, et al : Gabapentin for intractable hiccups in a patient undergoing peritoneal dialysis. Perit Dial Int 28 : 667-668, 2008

 

9) Hadjiyannacos D, Vlassopoulos D, Hadjiconstantinou V : Treatment of intractable hiccup in haemodialysis patients with baclofen. Am J Nephrol 21 : 427-428, 2001

PubMed

10) Chang JM, Hwang SJ, Kuo HT, et al : Fatal outcome after ingestion of star fruit (Averrhoa carambola) in uremic patients. Am J Kidney Dis 35 : 189-193, 2000

PubMed

11) Garcia-Cairasco N, Moyses-Neto M, Del Vecchio F, et al : Elucidating the neurotoxicity of the star fruit. Angew Chem Int Ed Engl 52 : 13067-13070, 2013

PubMed

12) McAuley JH, Rothwell JC, Marsden CD, et al : Electrophysiological aids in distinguishing organic from psychogenic tremor. Neurology 50 : 1882-1884, 1998

PubMed

P.324 掲載の参考文献

1) 西原舞, 平田純生, 和泉智, 他 : 透析患者の便秘症. 透析会誌 37 : 1887-1892, 2004

 

2) 和泉智 : 透析患者が自宅で服用するくすり : 下剤. 透析ケア 13 : 134-136, 2007

 

3) 武田宏司, 浅香正博 : III 症候編, 下痢. 内科診断学 第2版, 福井次夫, 奈良信夫監修, pp550-558, 医学書院, 東京, 2008

 

4) 宮川尚之, 植田拓也 : 透析患者に発症したランソプラゾール関連性collagenous colitisの1例. 透析会誌 43 : 843-846, 2010

 

5) 若杉三奈子, 市川紘将, 本間照, 他 : Collagenous colitisを合併した血液透析患者の1例. 透析会誌 43 : 999-1003, 2010

 

P.327 掲載の参考文献

1) 胃潰瘍診療ガイドラインの適正と評価に関する研究班編 : 内視鏡治療. EBM に基づく胃潰瘍ガイドライン 第2版, pp61-67, じほう, 東京, 2007

 

2) Srygley FD, Gerardo CJ, Tran T, et al : Does this patients have a severe upper gastrointestinal bleed? JAMA 307 : 1072-1079, 2012

PubMed

3) Lew SQ, Bosch JP : The digestive Tract. Handbook of dialysis 4th edition, pp601-610, Lippincott Williams & Wilkins, Philadelphia, 2006

 

4) Stefanidis I, Liakopoulos V, Kapsoritakis AN, et al : Gastric antral vascular ectasia (GAVE) in patients with ESRD. Am J Kidney Dis 47 : 77-82, 2006

 

5) Yasuda G, Shibata K, Takizawa T : Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients Am J Kidney Dis 39 : 1292-1299, 2002

PubMed

6) 宮崎滋, 山添千春, 横山恵美子, 他 : 透析患者のスクリーニング検査からの教訓と問題点腹部CT, 消化管内視鏡, PSA, BNP, HbA1Cなどを中心に. 日透医誌 21 (1) : 119-122, 2006

 

7) 山川智之 : 虚血性腸疾患の診断と治療は. EBM透析療法, pp454-457, 中外医学社, 東京, 2007

 

P.332 掲載の参考文献

1) 佐藤昌志, 金光峰子, 灰塚尚敏, 他 : 血液透析患者の「のどの渇き」について. 臨牀透析 26 : 137-141, 2010

 

2) 又賀泉 : 慢性腎不全透析療法中患者にみられる口腔乾燥に対する臨床的研究. 日口腔外会誌 29 : 1901-1920, 1983

 

3) 冨田寛 : 味覚障害診療の現況. JOHNS 18 : 871-877, 2002

 

4) 冨田寛 : 味覚障害の疫学と臨床像. 日医師会誌 142 : 2617-2622, 2014

 

5) 橋口誠一, 有薗健二, 福井博義 : 透析導入期患者の味覚障害について. 臨牀透析 16 : 141-144, 2000

 

P.335 掲載の参考文献

1) Krishnan AV, Pussell BA, Kiernan MC : Neuromuscular disease in the dialysis patient : an update for the nephrologist. Semin Dial 22 : 267-278, 2009

PubMed

2) Tilki HE, Akpolat T, Cos, kun M, et al : Clinical and electrophysiologic findings in dialysis patients. J Electromyogr Kinesiol 19 : 500-508, 2009

 

3) Bostock H, Walters RJL, Andersen KV, et al : Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy? Nephrol Dial Transplant 19 : 1054-1057, 2004

 

4) 木村哲也, 大生定義 : 末梢神経障害. 日本臨牀 24 : 867-869, 2008

 

5) Arnold R, Kwai NCG, Krishnan AV : Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies. Clin Neurophysiol 124 : 2079-2090, 2013

PubMed

P.338 掲載の参考文献

1) American Academy of Sleep Medicine : Obstructive Sleep Apnea Syndromes. International Classificaton of Sleep Disorders, 2nd ed : Diagnostic & Coding Manual. Sateia MJ (ed), pp51-59, American Academy Sleep Medicine, Westchester, Illinois, 2005

 

2) The Report of an American Academy of sleep Medicine Task Force : Sleep-related breathing disorders in adults : Recommendations foe syndrome definition and measurement techniques in clinical research. Sleep 22 : 667-689, 1999

 

3) Parker KP : Sleep disturbances in dialysis patients. Sleep Med Rev 7 : 131-143, 2003

PubMed

4) 睡眠呼吸障害研究会編 : 成人の睡眠時無呼吸症候群診断と治療のためのガイドライン, pp15-22, メディカルビュー社, 大阪, 2005

 

5) 佐藤誠 : パルスオキシメトリーの妥当性と限界. 睡眠時無呼吸症候群スクリーニングハンドブック, 谷川武編, pp44-48, 厚生科学研究所, 東京, 2004

 

P.340 掲載の参考文献

1) 葉山修陽, 栗原怜 : レストレスレッグス症候群. 腎と透析 72 (4) : 499-502, 2012

Medical*Online

2) 井上雄一, 内田直尚, 平田幸一 : Restless Legs Syndrome, pp9-11, pp16-17, アルタ出版, 東京, 2008

 

3) Winkelman JW : Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 70 (1) : 35-42, 2008

PubMed

4) 中里雄一, 他 : 経皮吸収型オピオイド鎮痛薬の中止によりレストレスレッグス症候群の著しい増悪をきたした血液透析患者の1例. 透析会誌 47 (2) : 145-149, 2014

 

P.343 掲載の参考文献

1) 内田直 : 安眠の科学, pp24-140, 日刊工業新聞社, 東京, 2013

 

2) 内山真 : 不眠症診療&マネジメントマニュアル, pp71-93, メディカ出版, 大阪, 2013

 

P.346 掲載の参考文献

1) Besarab A, Bolton WK, Browne JK, et al : The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 : 584-590, 1998

PubMed

2) K/DOQI : K/DOQI clinical practice guidelines and clinical recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47 (suppl 3) : S9-145, 2006

 

3) Kidney Disease : Improving Global Outcomes (KDIGO) Anemia Work Group : KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int (suppl 2) : 279-335, 2012

 

4) 日本透析医学会 : 2008年版「慢性腎臓病患者における腎性貧血治療のガイドライン」. 透析会誌 41 : 661-716, 2008

 

P.352 掲載の参考文献

1) Otaki Y, Nakanishi T, Hasuike Y, et al : Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis. Am J Kidney Dis 43 : 1030-1039, 2004

PubMed

2) Nakanishi T, Kuragano T, Nanami M, et al : Importance of ferritin for optimizing anemia therapy in chronic kidney disease. Am J Nephrol 32 : 439-446, 2010

PubMed

3) Nemeth E, Tuttle MS, Powelson J, et al : Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 : 2090-2093, 2004

PubMed

4) Kuragano T, Shimonaka Y, Kida A, et al : Determinants of hepcidin in patients on maintenance hemodialysis : role of inflammation. Am J Nephrol 31 (6) : 534-540, 2010

 

5) Hasuike Y, Nonoguchi H, Ito K, et al : Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol 30 : 389-398, 2009

PubMed

6) Nanami M, Ookawara T, Otaki Y, et al : Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol 25 : 2495-2501, 2005

PubMed

7) Bulteau AL, O'Neill HA, Kennedy MC, et al : Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305 (5681) : 242-245, 2004

PubMed

8) Hasuike Y, Nagai T, Yorifuji S, et al : The mitochondrial protein frataxin is downregulated in hemodialysis patients. Clin Exp Nephrol 17 (3) : 424-430, 2013

PubMed

9) Stadler N, Lindner RA, Davies MJ, et al : Direct detection and quantification of transition metal ions in human atherosclerotic plaques : evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 24 (5) : 949-954, 2004

PubMed

10) Drueke T, Witko-Sarsat V, Massy Z, et al : Iron herapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106 (17) : 2212-2217, 2002

 

11) 中西健 : 透析患者における "鉄の囲い込み" 異常 (DIMES症候群) -MIA症候群はDIMES症候群で起こるか-. 日透医会誌 19 : 468-504, 2004

 

12) Lynch SR, Skikne BS, Cook JD : Food iron absorption in idiopathic hemochromatosis. Blood 74 : 2187-2193, 1989

PubMed

13) Fillet G, Beguin Y, Baldelli L : Model of reticuloendothelial iron metabolism in humans : abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood 74 : 844-851, 1989

PubMed

14) Nakanishi T, Kuragano T, Kaibe S, et al : Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations? Clin Exp Nephrol 16 (6) : 819-826, 2012

PubMed

P.357 掲載の参考文献

1) Block GA, Klassen PS, Lazarus JM, et al : Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 : 2208-2218, 2004

PubMed

2) KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD). Kidney Int 76 (suppl 113) : S1-S130, 2009

 

3) Taal MW, Thurston V, McIntyre RJ, et al : The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease. Kidney Int 2014 [Epub ahead of print]

 

4) Massry SG, et al : K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Disease 42 (suppl 3) : S1-S202, 2003

 

5) 日本透析医学会ワーキンググループ : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 透析会誌 45 : 301-356, 2012

 

6) Kakuta T, Tanaka R, Hyodo T, Suzuki H, et al : Effect of Sevelamer and Calcium-Based Phosphate Binders on Coronary Artery Calcification and Accumulation of Circulating Advanced Glycation End Products in Hemodialysis Patients. Am J Kidney Dis 57 (3) : 422-431, 2011

PubMed

7) Tatsumi R, Sawada K, Kanai G, et al : Cinacalcet HCl Induces Apoptosis and Proliferation of Parathyroid Cells in Human : Histological and Cytological Analyses. Nephron Clin Pract 124 : 224-231, 2013

 

P.361 掲載の参考文献

1) Chen Y, Dokholyan NV : A single disulfide bond differentiates aggregation pathways of beta2-microglobulin. J Mol Biol 35 : 473-482, 2005

 

2) 西慎一, 乳原善文 : 透析アミロイドーシス. アミロイドーシス診療のすべて, 山田正仁編, pp87-101, 医歯薬出版株式会社, 東京, 2011

 

3) Koda Y, Nishi S, Miyazaki S, et al : Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52 : 1096-1101, 1997

PubMed

4) Kopec J, Gadek A, Drozdz M, et al : Carpal tunnel syndrome in hemodialysis patients as a dialysisrelated amyloidosis manifestation-incidence, risk factors and results of surgical treatment. Med Sci Monit 17 : CR505-509, 2011

PubMed

5) Baz Ml, Durand C, Ragon A, et al : Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 14 : 681-685, 1991

 

6) Gejyo F, Amano I, Ando T, et al : Survey of the effects of a column for adsorption of b2-microglobulin in patients with dialysis-related amyloidosis in Japan. Ther Apher Dial 17 : 40-47, 2013

 

P.365 掲載の参考文献

1) Gejyo F, Amano I, Ando T, Ishida M, et al : Survey of the effects of a column for adsorption of b2-microglobulin in patients with dialysis-related amyloidosis in Japan. Ther Apher Dial 17 : 40-47, 2013

 

2) 日本透析医学会 : 2011年度版慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 44 : 855-937, 2011

 

P.368 掲載の参考文献

1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2007年12月31日現在), 2008

 

2) 平成19年度厚生労働省科学研究費補助金 (肝炎等克服 1 緊急対策研究事業) 透析施設における標準的な透析操作と院内感染予防に関するマニュアル (三訂版), 2008

 

3) Ito K, Yotsuyanagi H, Yatsuhashi H, et al : Risk factors for long-termpersistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology 59 (1) : 89-97, 2014

 

4) Spaziante M, Biliotti E, Grieco S, et al : Anti-HBs Seroconversion During Treatment With Entecavir in a Patient With Chronic Hepatitis B Virus Infection on Hemodialysis. Journal of Medical Virology 86 : 139-143, 2014

 

5) Gerlach JT, Diepolder HM, Zachoval R, et al : Acute hepatitis C : high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125 : 80-88, 2003

PubMed

P.371 掲載の参考文献

1) 青池郁夫, 鈴木正司, 薄田芳丸 : 結核症の診断法. 臨牀透析 22 : 151-158, 2006

 

2) 佐々木結花, 山岸文雄, 森亨 : 血液透析患者における結核発症の現状. 結核 77 : 51-59, 2002

 

3) 舛本祥一, 井上剛, 片桐大輔, 他 : 原因不明の胸水貯留を繰り返し, 剖検にて尿毒症性胸膜炎と診断し得た維持透析患者の1例. 透析会誌 42 : 973-978, 2009

 

4) 中山均, 桜林耐, 宮崎滋, 他 : 透析患者の呼吸器合併症. IV 肺結核. 臨牀透析 24 : 1135-1142, 2008

 

5) 日ノ下文彦 : 結核-対策と最近の話題. 透析療法ネクスト VIII 感染症対策, 秋葉隆, 秋澤忠男編, pp74-83, 医学図書出版, 東京, 2009

 

6) 原田登之, 樋口一恵, 森亨 : QuantiFERON(R) TB第二世代の基礎的特性. 結核 80 : 774-777, 2005

 

7) Inoue T, Nakamura T, Katsuma A, et al : The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant 24 : 2252-2257, 2009

PubMed

8) Inoue T, Nangaku M, Hinoshita F : Tuberculous lymphadenitis in a dialysis patient diagnosed by 18-fluorodeoxyglucose positron emission tomography and IFN-γ release assay. Am J Kidney Dis 62 : 1221, 2013

 

9) Meler T, Eurenbruch HP, Wrighton-Smith P, Enders G, Regnath T : Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24 : 529-536, 2005

 

P.376 掲載の参考文献

1) 隈博政 : 新型インフルエンザ対策. 日透医誌 24 ; 349-361, 2009

 

2) Hayden FG, Fritz RS, Lobo MC, et al : Local and systemic cytokine response during experimental human influenzaA virus infection. J Clin Invest 101 : 643-649, 1998

 

3) 日本感染症学会提言2012, 「インフルエンザ病院内感染対策の考え方について (高齢者施設を含めて) 」http://www.kansensho.or.jp/influenza/1208_teigen.html

 

4) Fiore AE, Fry A, Shay D, et al : Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60 : 1-24, 2011

PubMed

5) 平成25年政府行動計画・ガイドラインを踏まえた「医療機関における新型インフルエンザ等対策立案のための手引き」 (平成25年9月暫定1.1版) http://dl.med.or.jp/dl-med/kansen/novel_influenza/guidelines_ver1.pdf

 

P.379 掲載の参考文献

1) Yanagisawa N, Ando M, Ajisawa A, et al : Clinical characteristics of kidney disease in Japanese HIV-infected patients. Nephron Clin Pract 118 (3) : c285-291, 2011

PubMed

2) Yanagisawa N, Muramatsu T, Yamamoto Y, et al : Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate. Clin Exp Nephrol. DOI 10.1007/s 10157-013-0853-1

 

3) Vigneau C, Guiard-Schmid JB, Tourret J, et al : The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002. Kidney Int 67 : 1509-1514, 2005

PubMed

4) Eggers PW, Kimmel PL : Is there an epidemic of HIV Infection in the US ESRD program? J Am Soc Nephrol 15 : 2477-2485, 2004

 

5) 秋葉隆, 日ノ下文彦 : HIV感染患者における透析医療の推進に関する調査. 透析会誌 46 : 111-118, 2013

 

6) 秋葉隆, 杉下弘章, 隈博政, 他 : HIV感染患者透析医療ガイドライン. 透析会誌 43 : 1-24, 2010

 

P.383 掲載の参考文献

1) 石川勲 : 多嚢胞化萎縮腎と腎癌-長期透析合併症, pp1-90, 金沢医科大学出版局, 内灘, 2006

 

2) Ishikawa I : Acquired Cystic Disease of the Kidney and Renal Cell Carcinoma-Complication of Long-Term Hemodialysis, pp1-111, Springer, Tokyo, 2007

 

3) 石川勲 : ACDKの実態. 日透医誌 23 : 179-187, 2008

 

4) Ishikawa I : Renal cell carcinoma in dialysis patients : Radiological imaging and pathology of renal cell carcinoma complicated with acquired cystic disease of the kidney. Malign Tumours 1 : 21-31, 2010

 

5) 石川勲 : 透析患者における腎癌の現況2004年度アンケート調査報告と1982年度からのまとめ. 透析会誌 38 : 1689-1700, 2005

 

6) Ishikawa I, Morita K, Hayama S, et al : Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography. Clin Exp Nephrol 15 : 136-140, 2011

PubMed

P.387 掲載の参考文献

1) Inamoto H, Ozaki R, Matsuzaki T, Wakui M, et al : Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 59 (4) : 611-617, 1991

PubMed

2) Maisonneuve P, Agodoa L, Gellert R, et al : Cancer in patients on dialysis for end-stage renal disease : an international collaborative study. Lancet 354 (9173) : 93-99, 1999

PubMed

3) Iseki K, Osawa A, Fukiyama K : Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 22 (2) : 308-313, 1993

PubMed

4) System URD : USRDS 2004 annual data report. Am J Kidney Dis 45 (suppl 1) : S1, 2005

 

5) LeBrun CJ, Diehl LF, Abbott KC, Welch PG, et al : Life expectancy benefits of cancer screening in the endstage renal disease population. Am J Kidney Dis 35 (2) : 237-243, 2000

PubMed

6) Holley JL : Screening, diagnosis, and treatment of cancer in long-term dialysis patients. Clin J Am Soc Nephrol 2 (3) : 604-610, 2007 doi : 10.2215/CJN. 03931106.

 

7) 海津嘉蔵, 田中寧子, 徳井教孝 : 血液透析患者とがんの関係. 診断と治療 101 (7) : 1071, 2013

Medical*Online

8) 秋澤忠男監, 深川雅史編 : 検査値の読み方第3版, 日本メディカルセンター, 東京, 2013

 

9) 平田純生 : 腎不全と薬の使い方, じほう, 東京, 2005

 

10) Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, et al : American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract 6 (6) : 317-320, 2010 doi : 10.1200/JOP.2010.000132.

 

11) Nayak-Rao S, McConmick B : Ery thropoietin use in CKD patients with cancer : to tread with caution? J Nephrol 26 (5) : 829-835, 2013 doi : 10.5301/jn.5000316.

 

P.390 掲載の参考文献

1) 服部瑛 : 透析患者の皮膚科における現状と展望. Visual Dermatology 3 : 464-467, 2004

 

2) Tominaga M, Takamori K : Recent advances in pathophysiological mechanisms of itch. Expert Rev Dermatol 5 : 197-212, 2010

 

3) Patterson JW : The perforating disease. J Am Acad Dermatol 10 : 561-581, 1984

 

4) 小林桂子, 森田明理, 松岡慎 : Calciphylaxisによる皮膚石灰沈着症-体幹部に広範な潰瘍を生じた症例-. 皮膚病診療 25 : 517-520, 2003

 

5) 柳原誠, 土肥庄二郎, 角田孝彦, 他 : 透析アミロイドーシス. Visual Dermatology 5 : 502-505, 2004

 

P.395 掲載の参考文献

1) Yosipovitch G, Bernhard JD : Chronic pruritus. N Engl J Med 368 : 1625-1634, 2013

PubMed

2) Narita I, Alchi B, Gejyo F, et al : Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 69 : 1626-1632, 2006

PubMed

3) Kumagai H, Saruta T, Utsumi J, et al : Prospects for a novel k-opioid receptor agonist, TRK-820, in uremic pruritus. Itch : Basic mechanisms and therapy, Yosipovitch G (ed). pp279-286, Marcel Dekker, New York 2004

 

4) Kumagai H, Takamori K, Suzuki H, et al : Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients : a Phase III, randomised, double-blind, placebo-controlled study. Nephrol Dial Transplant 25 : 1251-1257, 2010

PubMed

5) 熊谷裕生, 江畑俊哉, 鈴木洋通, 他 : 血液透析患者のかゆみに対する, カッパ受容体作動薬ナルフラフィンの有効性. 日透医会誌 24 : 387-395, 2009

 

6) Kumagai H, Ebata T, Takamori K, et al : Efficacy and Safety of a Novel Kappa-Agonist for Managing Intractable Pruritus in Dialysis Patients. Am J Nephrol 36 : 175-183, 2012

PubMed

P.398 掲載の参考文献

1) 加賀達志, 野口真由美, 内藤尚久, 市川一夫, 他 : 血液透析中にのみ高眼圧を認めた開放隅角緑内障の1症例. 臨床眼科 44 (8) : 1251-1255, 1990

 

2) Tawara A, Kobata H, Fujisawa K, Abe T, et al : Mechanism of intraocular pressure elevation during hemodialysis. Curr Eye Res 7 : 339-347, 1998

 

3) 市川一夫 : 特集糖尿病と内眼手術糖尿病性透析患者の内眼手術について. 眼科手術 7 (4) : 557-563, 1994

 

4) 中目沙衣子, 渡辺博, 田中康一郎, 他 : ハイドロフィリックアクリル眼内レンズのカルシウム沈着に関する前房水の組成分析. 臨床眼科 58 (10) : 1915-1918, 2004

 

5) 野口真由美, 加賀達志, 市川一夫 : 糖尿病透析患者の硝子体手術, 燃え尽き網膜症に対する硝子体手術. 眼科臨床医報 90 (6) : 58-60, 1996

 

6) Ozdemir M, Bakaris S, Ozdemir G, Buyukbese MA, et al : Ocular surface disorders and tear function changes in patients with chronic renal failure. Can J Ophthalmol 7 : 526-532, 2004

 

P.402 掲載の参考文献

1) Ahmed EA : Erectile dysfunction in hemodialysis : A systematic review. World J Nephrol 1 (6) : 160-165, 2012

 

2) 守尾友宏, 新井貴士, 桑田昇治 : [尿毒症・慢性透析にみられる合併症と関連する諸物質] 性機能障害. 臨牀透析 21 : 1289-1296, 2005

 

3) 正木浩哉, 西川光重 : 透析患者の性機能障害. 日本臨牀 62 (増刊 6) : 549-552, 2004

 

4) 兵藤透, 山本スミ子, 馬場志郎 : バイアグラ希望血液透析患者のQOL, 性機能およびその投与治療経験と現時点における本邦および海外における投与状況. 透析会誌 37 : 1475-1478, 2004

 

5) Lawrence IG, Price DE, Howlett TA, et al : Correcting impotence in the male dialysis patient : experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis 31 : 313-319, 1998

PubMed

6) Mehrsai A, Mousavi S, Nikoobakht M, et al : Improvement of erectile dysfunction after kidney transplantation : the role of the associated factors. Urol J 3 (4) : 240-244, 2006

PubMed

P.407 掲載の参考文献

1) Fougue D, Kalantar-Zadeh K, Kopple J, et al : A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73 : 391-398, 2008

 

2) Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, et al : Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15 : 953-960, 2000

PubMed

3) Rosenberg IH : Sarcopenia : origins and clinical relevance. J Nutr 127 : 990s-991s, 1997

PubMed

4) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, et al : Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 : 412-423, 2010

 

5) Clark BC, Manini TM : Sarcopenis≠dynapenia. J Gerontol A Biol Sci Med Sci 63 : 829-834, 2008

 

6) Morley JE, Abbatecola AM, Argiles JM, Baracos V, et al : Sarcopenia with limited mobility : an international consensus. J Am Med Dir Assoc 12 : 403-409, 2011

PubMed

7) Baumgartner RN, Koehler KM, Gallagher D, Romero L, et al : Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147 : 755-763, 1998

PubMed

8) Pifer TB, Mccullough KP, Port FK, Goodkin DA, et al : Mortality risk in hemodialysis patients and changes in nutritional indicators : DOPPS. Kidney Int 62 : 2238-2245, 2002

PubMed

9) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2008年12月31日現在). 2009

 

10) Detsky AS, McLaughlin JR, Baker JP, Johnston N, et al : What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 11 : 8-13, 1987

PubMed

11) Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH : A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38 : 1251-1263, 2001

PubMed

12) Bouillanne O, Morineau G, Dupont C, Coulombel I, et al : Geriatric nutritional risk index : a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 82 : 777-783, 2005

PubMed

13) Kobayashi I, Ishimura E, Kato Y, Okuno S, et al : Geriatric nutritional risk index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patietns. Nephrol Dial Transplant 25 : 3361-3365, 2010

 

14) Yamada K, Furuya R, Takaita T, Maruyama Y, et al : Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 87 : 106-113, 2008

 

P.410 掲載の参考文献

1) 日本透析医学会 : 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 44 : 337-425, 2011

 

2) 日本動脈硬化学会, 動脈硬化性疾患予防ガイドライン 2012, 協和企画, 東京, 2012

 

3) 日本腎臓学会 : エビデンスに基づくCKD診療ガイドライン. 第14章 CKDと脂質異常症. 日腎会誌 55 : 151-156, 2013

 

4) KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease. Kidney Int (suppl 3) : 259-305, 2013

 

5) Rogacev KS, Pinsdorf T, Weingartner O, et al : Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients. Clin J Am Soc Nephrol 7 : 943-948, 2012

PubMed

6) Sonoda M, Shoji T, Kimoto E, et al : Kidney Function, Cholesterol Absorption and Remnant Lipoprotein Accumulation in Patients with Diabetes Mellitus. J Atheroscler Thromb 21 (4) : 346-354, 2014

PubMed

7) Shoji T, Kakiya R, Hayashi T, et al : Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients. Am J Kidney Dis 62 : 568-576, 2013

 

P.414 掲載の参考文献

1) DeFronzo RA, Alvestrand A, Smith D, et al : Insulin resistance in uremia. J Clin Invest 67 : 563-568, 1981

PubMed

2) Gerich JE, Meyer C, Woerle HJ, et al : Renal gluconeogenesis : Its importance in human glucose homeostasis. Diabetes Care 24 : 382-391, 2001

PubMed

3) Takahashi A, Kubota T, Shibahara N, et al : The mechanism of hypoglycemia caused by hemodialysis. Clin Nephrol 62 : 362-368, 2004

PubMed

4) Abe M, Kikuchi F, Kaizu K, et al : The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis. Clin Nephrol 69 : 354-360, 2008

PubMed

5) Ricks J, Molnar MZ, Kovesdy CP, et al : Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes. Diabetes 61 : 708-715, 2012

PubMed

6) Inaba M, Maekawa K, Okuno S, et al : Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis. Clin Nephrol 78 : 273-280, 2012

PubMed

7) 石井晶子, 馬場園哲也, 春山賢介, 他 : 糖尿病透析患者における網膜症の年次的変化. 糖尿病 45 : 737-742, 2002

 

8) Jacobsen LV, Hindsberger C, Robson R, et al : Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide. Br J Clin Pharmacol 68 : 898-905, 2009

PubMed

P.417 掲載の参考文献

1) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al : Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 : 412-423, 2010

 

2) Wakabayashi H, Sashika H : Malnutrition is associated with poor rehabilitation outcome in elderly inpatients with hospital-associated deconditioning : a prospective cohort study. J RehabilMed, doi : 10.2340/16501977-1258. 2013 [Epub ahead of print]

 

3) Noori N, Kopple JD, Kovesdy CP, et al : Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5 : 2258-2268, 2010

PubMed

4) 下方浩史, 安藤富士子 : サルコペニア-研究の現状と未来への展望-1. 日常生活機能と骨格筋量, 筋力との関連. 日老医誌 49 : 195-198, 2012

 

5) 若林秀隆 : 高齢者リハビリテーション栄養, カイ書林, 東京, 2013

 

6) Bauer J, Biolo G, Cederholm T, et al : Evidence-based recommendations for optimal dietary protein intake in older people : a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14 : 542-559, 2013

 

7) Heiwe S, Jacobson SH : Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev 2011 : CD003236

PubMed

P.422 掲載の参考文献

1) 日本透析医学会 : 2011年版慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 透析会誌 44 (9) : 855-937, 2011

 

2) バスキュラーアクセスの治療と管理-未来に向けて-, 大平整爾監修・編集, 東京医学社, 東京, 2011

 

3) バスキュラーアクセス診断学, 大平整爾監修, 春口洋昭編集, 中外医学社, 東京, 2012

 

4) バスキュラーアクセス治療学, 大平整爾監修, 春口洋昭編集, 中外医学社, 東京, 2013

 

P.425 掲載の参考文献

1) 窪田実 : ペリトネアルアクセス. 腎と透析 65 (増刊号) : 193-196, 2008

 

2) 窪田実 : 腹膜透析療法の新展開腹膜透析カテーテル留置術とトラブルシューティングの現況と進歩. 医学のあゆみ 239 : 746-751, 2011

 

3) 丹野有道 : 出口部感染・カテーテルトラブル. 腹膜透析マニュアル, 細谷龍男監修, pp181-188, 東京医学社, 東京, 2011

 

4) 国際腹膜透析学会ガイドライン・勧告腹膜透析関連感染症に関する勧告 : 2010年改訂腹膜透析アクセスに関する臨床実践ガイドライン. Current Topics on Peritoneal Dialysis 27 (suppl 1) : 3-4, 2010

 

5) 日本透析医学会統計調査委員会編 : わが国の慢性透析療法の現況 (2012年12月31日現在), 日本透析医学会, 2013

 

6) 今田聰雄 : CAPD関連腹膜炎・出口部感染の20年の軌跡と最新情報. 腎と透析61別冊腹膜透析 2006 : 94-97, 2006

 

P.430 掲載の参考文献

1) 野本保夫, 川口良人, 酒井信治, 他 : 硬化性被嚢性腹膜炎 (sclerosing encapsulating peritonaitis, SEP) 診断・治療指針 (案) -1996年における改訂-. 透析会誌 30 (7) : 1013-1022, 1997

 

2) 日本透析医学会 : 腹膜透析ガイドライン. 透析会誌 42 (4) : 285-315, 2009

 

3) Nakamoto H : Encapsulating peritoneal sclerosis-a clinician's approach to diagnosis and medical treatment. Perit Dial Int 25 (suppl 4) : S30-S38, 2005

 

4) Kawaguchi Y, Saito A, Kawanishi H, et al : Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005 : Diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 25 (suppl 4) : S83-S95, 2005

 

5) Yamamoto T, Nagasue K, Okuno S, et al : The roll of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int 30 (3) : 343-352, 2010

 

6) Brown EA, Van Biesen W, Finkelstein FO, et al : Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis : Position paper for ISPD. Perit Dial Int 29 (6) : 595-600, 2009

PubMed

P.433 掲載の参考文献

1) 日本透析医学会統計調査委員会 : 図説 わが国の透析療法の現況 (2012年12月31日現在), 2014

 

2) Allon M, Depner TA, Radeva M, et al : Impact of dialysis dose and membrane on infection-related hospitalization and death : results of the HEMO Study. J Am Soc Nephrol 14 : 1863-1870, 2003

PubMed

3) Mermel LA, Allon M, Bouza E, et al : Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection : 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49 : 1-45, 2009

 

4) Li PK, Szeto CC, Piraino B, et al : Peritoneal dialysisrelated infections recommendations : 2010 update. Perit Dial Int 30 (4) : 393-423, 2010

PubMed

P.438 掲載の参考文献

1) 「腎と透析」編集委員会編 : 「腎疾患治療薬マニュアル 2013-14」. 腎と透析 74 (増刊号) : 2013

 

2) 腎臓専門医が受ける薬剤使用コンサルテーション. 腎と透析 74 (3) : 332-445, 2013

 

3) 腎不全時の薬物使用 (成人および小児における適正投与時のガイドライン 第5版). 臨牀透析 23 (14) : 2007

 

4) 透析患者のC型ウイルス肝炎治療ガイドライン. 透析会誌 44 (6) : 481-531, 2011

 

P.441 掲載の参考文献

1) 日本腎臓学会 : CKDと栄養, CKD診療ガイドライン 2013. 日腎会誌 55 : 25-30, 2013

 

2) 日本腎臓学会 : 慢性腎臓病に対する食事療法基準 2007年版. 日腎会誌 49 : 871-878, 2007

 

3) 厚生労働省 : 日本人の食事摂取基準 2010年版, 第一出版, 東京, 2009

 

4) 日本透析医学会 : 腹膜透析ガイドライン 2009. 透析会誌 42 : 285-315, 2009

 

5) Kalanter-Zadeh K, Ikizler TA, Block G, et al : Malnutrition-inflammation complex syndrome in dialysis patients : causes and consequences. Am J Kidney Dis 42 : 864-881, 2003

 

6) Yamada K, Furuya R, akita T, et al : Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 87 : 106-13, 2008

 

7) Avesani CM, Kamimura MA, Cuppari L : Energy expenditure in chronic kidney disease patients. Journal of Renal Nutrition 21 : 27-30, 2011

PubMed

8) Shinaberger CS, Kilpatrick RD, Regidor DL, et al : Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 48 : 37-49, 2006

PubMed

9) Pasticci F, Fantuzzi AL, Pegoraro M, et al : Nutritional management of stage 5 chronic kidney disease. Journal of Renal Care 38 (1) : 50-58, 2012

PubMed

P.444 掲載の参考文献

1) 熊谷裕通 : 透析患者の栄養障害とは? 臨牀透析 29 : 1169-1174, 2013

 

2) 本田浩一, 他 : 透析患者の栄養障害と管理. 医学のあゆみ 7 : 456-459, 2008

 

3) 日本腎臓学会 : 慢性腎臓病に対する食事療法基準 2007年度版. 日腎会誌 49 : 871-878, 2007

 

4) Ikizler TA : Protein and energy intake in advanced chronic kidney disease : how much is too much? Semin Dial 20 (1) : 5-11, 2007

PubMed

5) 日本透析医学会 : 血液透析患者の糖尿病治療ガイド 2012. 透析会誌 46 : 345-347, 2013

 

P.447 掲載の参考文献

1) 日本腎臓学会 : 慢性腎臓病に対する食事療法基準 2007年版. 日腎会誌 49 (8) : 871-878, 2007

 

2) 日本透析医学会 : 2009年版腹膜透析ガイドライン. 透析会誌 42 (4) : 285-315, 2009

 

3) Ishizaki M, Yamashita A, Kwanishi H, et al : Dialysis dose and nutrition in Japanese peritoneal dialysis patients. Adv Perit Dial 20 : 141-143, 2004

 

4) 厚生労働省日本人の食事摂取基準策定検討会 : 日本人の食事摂取基準 (2010年版), 第一出版, 東京, 2010

 

P.450 掲載の参考文献

1) O'Hare AM, et al : Decreased survival among sedentary patients undergoing dialysis, results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis 41 : 447-454, 2003

PubMed

2) K/DOQI Workgroup : K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (suppl 3) : S1-S153, 2005

 

3) 伊藤修 : 透析患者のリハビリテーション-現状と問題点 運動療法の実際と効果. Journal of Clinical Rehabilitation 19 : 531-537, 2010

 

4) Konstantinidou E, Koukouvou G, Kouidi E, et al : Exercise training in patients with end-stage renal disease on hemodialysis : comparison of three rehabilitation programs. J Rehabil Med 34 : 40-45, 2002

PubMed

5) 齋藤正和, 松永篤彦, 坂本純子, 他 : 維持血液透析を受けている虚血性心疾患患者に対する心臓リハビリテーションの現状と課題. 心臓リハビリテーション 10 : 120-123, 2005

 

6) Kutner NG, Zhang R, Huang Y, et al : Cardiac rehabilitation and survival of dialysis patients after coronary bypass. J Am Soc Nephrol 17 : 1175-1180, 2006

PubMed

P.453 掲載の参考文献

1) Ndip A, Lavery LA, Boulton AJM : Diabetic foot disease in people with advanced nephropathy and those on renal dialysis. Curr Diab Rep 10 (4) : 283-290, 2010

PubMed

2) Ndip A, Rutter MK, Vileikyte L, et al : Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 33 (8) : 1811-1816, 2010

PubMed

3) Margolis DJ, Hofstad O, Feldman HI : Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 31 (7) : 1331-1336, 2008

PubMed

4) Valabhji J : Foot problems in patients with diabetes and chronic kidney disease. J Ren Care 38 (suppl 1) : 99-108, 2012

 

5) 新城孝道 : 糖尿病のフットケア, pp8-28, 歯薬出版, 東京, 2011

 

腎不全の課題

P.458 掲載の参考文献

1) http://www.taiseikai.jp/jspn25/

 

2) 安田貴昭, 五十嵐友里, 堀川直史 : プライマリケアにおけるうつ病診療の実態 : 「Collaborative Care (協同的ケア) 」を実施するための予備調査. 精神科治療学 28 : 941-950, 2013

 

3) Bower, P., Gilbody, S., Richards, D. et al. : Collaborative care for depression in primary care. Making sense of a complex intervention : systematic review and meta-regression. Br J Psychiatry 189 : 484-493, 2006

PubMed

4) http://www.saitama-med.ac.jp/kawagoe/04departments/dep09psy/index2.html

 

5) 堀川直史 : 透析患者にみられる精神障害. 診断と治療 101 : 1041-1047, 2013

Medical*Online

6) 堀川直史, 志賀浪貴文 : 認知症. 腎と透析 76 (増刊号) : 314-316, 2014

 

P.461 掲載の参考文献

1) 岡田一義 : これからの終末期医療-現状と未来-. 腎と透析 73 : 421-426, 2012

Medical*Online

2) 岡田一義 : 超高齢者医療における倫理的側面を考える. 腎と透析 71 : 409-413, 2011

Medical*Online

3) 厚生労働省 : 終末期医療の決定プロセスに関するガイドライン http://www.mhlw.go.jp/shingi/2007/05/dl/s0521-11a.pdf (access 2014.1.8)

 

4) 岡田一義 : 終末期における「透析中止」. 透析会誌 41 : 29-37, 2008

 

5) 岡田一義 : 透析患者の終末期における治療見合わせ. 大阪透析研究会会誌 30 : 5-8, 2012

Medical*Online

6) 岡田一義, 今田聰雄, 海津嘉蔵, 他 : 透析医への意識調査 : 維持血液透析患者の悪性腫瘍終末期における透析中止について. 透析会誌 36 : 1315-1326, 2003

 

7) 岡田一義, 大平整爾, 伊丹儀友, 他 : 慢性血液透析療法の導入と終末期患者に対する見合わせに関する提言 (案). 透析会誌 45 : 1090-1095, 2012

 

8) 日本透析医学会 : 維持血液透析の開始と継続に関する意思決定プロセスについての提言 (案). http://www.jsdt.or.jp/info/1569.html (access 2014.1.8)

 

9) Carson RC, Juszczak M, Davenport A, et al : Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J AmSoc Nephrol 4 : 1611-1619, 2009

 

10) Chandna SM, Silva-Gane MD, Marshall C, et al : Survival of elderly patients with stage 5 CKD : comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 26 : 1608-1614, 2011

 

11) 日本透析医学会 : 図説わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

P.465 掲載の参考文献

1) 中澤了一, 他 : 透析患者の高齢化に伴う収容施設の相互連携に関するアンケート調査. 日透医誌 21 (1) : 161-169, 2005

 

2) 杉崎弘章, 他 : 透析患者の高齢化・長期化による問題点と透析提供体制に関する将来予測-アンケート調査-. 日透医誌 28 (1) : 80-93, 2013

 

3) 太田圭洋, 他 : 通院困難な透析患者への対応, 及び長期入院透析患者の実態調査. 日透医誌 22 (3) : 342-357, 2007

 

4) 太田圭洋, 他 : 「特定除外制度の廃止方針に対するアンケート調査」結果報告. 日透医誌 27 (3) : 468-477, 2012

 

P.468 掲載の参考文献

1) 日本移植学会 : ファクトブック 2013 http://www.asas.or.jp/jst/pdf/factbook/factbook2013.pdf

 

2) Butler JA, Peveler RC, Roderick P, Horne R, et al : Measuring compliance with drug regimens after renal transplantation : Comparison of self-report and clinician rating with electronic monitoring. Transplantation 77 : 786-789, 2004

PubMed

3) Denhaerynck K, Dobbels F, Cleemput I, et al : Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients : a literature review. Transpl Int 18 (10) : 1121-1133, 2005

PubMed

4) Chisholm-Burns M, Pinsky B, Parker G, Johnson P, et al : Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant 26 (5) : 706-713, 2012

PubMed

5) Fine RN, Becker Y, De Geest S, Eisen H, et al : Nonadherence consensus conference summary report. Am J Transplant 9 : 35-41, 2009

PubMed

6) Morrissey PE, Flynn ML, Lin S : Medication noncompliance and its implications in transplant recipients. Drugs 67 (10) : 1463-1481, 2007

PubMed

7) De Bleser L, Matteson M, Dobbels F, et al : Interventions to improve medication-adherence after transplantation : a systematic review. Transpl Int 22 : 780-797, 2009

PubMed

P.472 掲載の参考文献

1) American Academy of Pediatrics ; American Academy of Family Physicians ; American College of Physicians ; Transitions Clinical Report Authoring Group, Cooley WC, Sagerman PJ : Supporting the health care transition from adolescence to adulthood in medical home. Pediatrics 128 (1) : 182-200, 2011

 

2) Bell L : Adolescent dialysis patient transition to adult care : a cross-sectional survey. Pediatr Nephrol 22 : 720-726, 2007

 

3) Ishikura K, Uemura O, Ito S, Wada N, et al : Predialysis chronic kidney disease in children : results of a nationwide survey in Japan. Nephrol Dial Transplant 28 : 2345-2355, 2013

PubMed

4) Blum RW, Garell D, Hodgman CH, Jorissen TW, et al : Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 14 : 570-576, 1993

 

5) Rosen DS, Blum RW, Britto M, Sawyer SM, et al ; Society for Adolescent Medicine : Transition to adult health care for adolescents and young adults with chronic conditions : position paper of the Society for Adolescent Medicine. J Adolesc Health 33 : 309-311, 2003

 

6) Watson AR : Problems and pitfalls of transition from paediatric to adult renal care. Pediatr Nephrol 20 : 113-117, 2005

PubMed

7) Watson AR : Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14 : 469-472, 2000

PubMed

8) Watson AR, Harden P, Ferris M, Kerr PG, et al : Transition from pediatric to adult renal services : a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol 26 : 1753-1757, 2011

PubMed

9) 本田雅敬 : 小児CKD患者の移行医療. 日児腎不全誌 33 : 5-9, 2013

 

10) 田崎あゆみ, 上村治 : 慢性腎臓病 (CKD) を持つ子どもの移行に伴う問題点と対策. Nursing Today 26 : 37-43, 2011

Medical*Online

11) American Academy of Pediatrics Committee on Drugs : Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 89 : 1110-1115, 1992

 

腎移植

P.478 掲載の参考文献

1) Murray JE, Harrison JH : Surgical management of fifty patients with kidney transplants including eighteen pairs of twins. Am J Surg 15 : 205-218, 1963

 

2) 太田和夫 : 移植グラフィティー (14)

 

3) Delmonic FL, Sheehy E, Marks WH, Baliga P, et al : Organ donation and utilization in the United States, 2004. Am J Transplant 5 : 862-873, 2005

 

4) 日本移植学会 : 日本移植学会倫理指針, http://www.asas.or.jp/jst/

 

5) 日本移植学会 : 臓器移植ファクトブック 2012, http://www.asas.or.jp/jst/pro/pro8.html

 

6) A report of the Amsterdam Forum on the care of the live kidney donor : Data and medical guidelines. Transplantation 79 : 553-556, 2005

 

7) Ellison MD, McBride MA, Taranto SE, Delmonico FL, et al : Living kidney donors in need of kidney transplants : A report from the organ procurement and transplantation network. Transplantation 74 : 1349-1351, 2002

PubMed

8) Kido R, Shibagaki Y, Iwado K, Nakajima I, et al : How do living kidney donors develop end-stage renal disease? Am J Transplant 9 (11) : 2514-2519 ,2009

 

9) Ratner LE, Ciseck Lj, et al : Laparoscopic live donor nephrectomy. Transplantation 60 : 1047-1049, 1995

PubMed

P.482 掲載の参考文献

1) 日本臓器移植ネットワーク : 移植に関するデータ http://www.jotnw.or.jp/

 

2) Hoshinaga K, Shiroki R, Fujita, T, et al : The fate of 359 renal allografts harvested from non-heart beating cadaver donors at a single center. Clinical Transplants, pp213-220, UCLA Tissue Typing Laboratory, Los Angeles, 1998

 

3) 日下守, 星長清隆 : 脳死下献腎移植と心停止下献腎移植の現状と問題点. 移植 47 (1) : 21-26, 2012

Medical*Online

4) International Registry in Organ Donation and Transplantation (IRODaT) http://www.irodat.org/

PubMed

5) 特集 : 献腎摘出-改正臓器移植法に対応して-. 腎移植血管外科 23 (2) : 2011

 

6) 日下守, 星長清隆 : 献腎採取と腎保存. 腎と透析 75 (1) : 99-102, 2013

Medical*Online

P.487 掲載の参考文献

1) Dustin ML : Cooedination of T cell activation and migration through formation of the immunologic synapse. Ann NY Aca Sci 987 : 51-19, 2003

 

2) Weiss A, Samelson LE : T-lymphocyte activation. Fundamental immunology, Paul WE (ed), pp321-363, Lippincott, Philadelphia, 2003

 

3) Cambell PM, Halloran P : T cell activation. Transplantation Biology-Cellular and molecular aspect, Tilney NL, Strom TB, Paul LC (eds), pp411-434, Lippincott, Philadelphia, 1996

 

4) Berke G : Cytotoxic T cells and mechanism of tissue injury. Transplantation Biology-Cellular and molecular aspect, Tilney NL, Strom TB, Paul LC (eds), pp435-455, Lippincott, Philadelphia, 1996

 

5) Kupiec-Weglinski JW, et al : Hyperacute and accelerated allograft rejection. Transplantation Biology-Cellular and molecular aspect, Tilney NL, Strom TB, Paul LC (eds), pp541-556, Lippincott, Philadelphia, 1996

 

P.493 掲載の参考文献

1) Sis B, Mengel M, Haas M, et al : Banff '09 meeting report : Antibody mediated graft deterioration and implementation of Banff Working Groups. Am J Transplant 10 : 464-471, 2010

PubMed

2) Broecker V, Schubert V, Scheffner I, et al : Arterolar lesions in renal transplant biopsied. Am J Pathol 180 : 1852-1862, 2012

 

3) Matsutani K, Shapiro R, Tan H, et al : Th Banff 2009 working proposal for polyomavirus nephropathy : S critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant 12 : 907-918, 2012

 

P.496 掲載の参考文献

1) 腎移植臨床登録集計報告 (2013) 2012年実施症例の集計報告. 移植 48 : 341-360, 2013

 

2) Matas AJ, Smith JM, Skeans MA, Lamb KE, et al : OPTN/SRTR 2011 Annual Data Report : kidney. Am J Transplant 13 (suppl 1) : 11-46, 2013

 

3) Tyden G, Kumlien G, Fehrman I : Successful ABO-incompatible kidney transplantationswithout splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 76 (4) : 730-731, 2003

PubMed

4) Gloor JM, DeGoey S, Ploeger N, Gebel H, et al : Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 78 (2) : 221-227, 2004

PubMed

5) Fehr T, Gaspert A : Antibody-mediated kidney allograft rejection : therapeutic options and their experimental rationale. Transpl Int 25 (6) : 623-632, 2012

PubMed

6) Lamb KE, Lodhi S, Meier-Kriesche HU : Long-term renal allograft survival in the United States : a critical reappraisal. Am J Transplant 11 : 450-462, 2011

PubMed

P.499 掲載の参考文献

1) Dragun D, Muller DN, Brasen JH, et al : Angiotensin II type 1-receptor activating antibodies in renalallograft rejection. N Engl J Med 352 : 558-569, 2005

PubMed

2) Brennan DC, Daller JA, Lake KD, et al : Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 355 : 1967-1977, 2006

PubMed

3) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S1-S157, 2009

 

4) Arnold LW, McCray SK, Tatu C, et al : Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo : cyclosporin A blocks differentiation to B-1. J Immunol 164 : 2924-2930, 2000

 

5) Chikaraishi T, Sasaki H, Tsutsumi H, et al : ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab. Transplant Proc 40 : 3445-3447, 2008

PubMed

P.502 掲載の参考文献

1) Webster AC, Woodroffe RC, Taylor RS, et al : Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients : metaanalysis and meta-regression of randomized trial data. BMJ 331 : 810-821, 2005

PubMed

2) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (supple 3) : S1, 2009

 

3) Niioka T, Sato S, Kagaya H, et al : Comparison of Pharmacokinetics and Phamacogenetics of Once- and Twice-Dialy Tacrolimus in the Early Stage After Renal Transplantation. Transplantation 94 (10) : 1013-1019, 2012

 

4) Kumar MSA, Heifets M, Fyfe B, et al : Comparison of Steroid Avoidance in Tacrolimus/Mycophenolate Mofetil and Tacrolimus/Sirolimus Combination in Kidney Transplantation Monitored by Surveillance Biopsy. Transplantation 80 (6) : 807-814, 2005

 

5) Budde K, Becker T, Arns W, et al : Everolimus-based, calcineurin-inhibitor-free regimen in recipients of denovo kidney transplants : an open-label, randomised, controlled trial. Lancet 377 (9768) : 837-847, 2011

PubMed

P.505 掲載の参考文献

1) 寺岡慧, 甲斐耕太郎 : 腎移植における拒絶反応の分類と機序. 腎移植の進歩, わが国の現状と今後の展望, 日本腎臓学会渉外・企画委員会/腎移植推進委員会編, pp111-123, 東京医学社, 東京, 2006

 

2) 河村毅, 相川厚 : 腎移植-腎移植に使用される使用薬剤, ステロイド. 腎と透析 74 (増刊号) : 713-717, 2013

 

3) 清水朋一, 田邉一成 : 腎移植-腎移植に使用される使用薬剤, デオキシスパーガリン. 腎と透析 74 (増刊号) : 739-741, 2013

 

4) 渕之上昌平 : 腎移植-腎移植に使用される使用薬剤, サイモグロブリン. 腎と透析 74 (増刊号) : 750-753, 2013

 

5) Haas M, Sis B, Racusen LC, et al : Banff 2013 meeting report : inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14 : 272-283, 2014

PubMed

6) Chapter 6 : Treatment of Acute Rejection, KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S21-S22, 2009

 

7) 両角國男, 武田朝美, 打田和治 : 移植腎長期生着向上に向けて. 腎移植の進歩, わが国の現状と今後の展望, 日本腎臓学会渉外・企画委員会/腎移植推進委員会編, pp265-275, 東京医学社, 東京, 2006

 

P.508 掲載の参考文献

1) Murray JE, et al : Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 268 : 1315, 1963

PubMed

2) 岡隆宏, 吉村了勇 : 移植と拒絶反応. 外科診療 35 : 35-37, 1993

 

3) Oka T, Ohmori Y, et al : Combination therapy of CyA and Az in living related kidney transplant recipients compared with patients converted totally from CyA to Az. Transplant Proc 20 : 143-146, 1988

 

4) Oka T, Ohmori Y, et al : The fate of living related donor kidney recipients after conversion from CyA to Az. Transplant Proc 19 : 2012-2013, 1987

 

P.512 掲載の参考文献

1) Yoshimura N, Ushigome H, Nobori S, Suzuki T, et al : Excellent results of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplant recipients-4-year results. Transplant Proc 45 : 1472, 2013

PubMed

2) Mizuno K, Tsujino M, Takada M, et al : Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot 27 : 775, 1994

 

3) Tanabe K, Tokumoto T, Ishikawa N, et al : Long-term results in mizoribine-treated renal transplant recipients : a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppressant. Transpl Proc 31 : 2877, 1999

 

4) Shiraki K, Ishibashi M, Okuno T, Kokado Y, et al : Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus. Transplant Proc 22 (4) : 1682, 1990

PubMed

5) 白木公康 : ミゾリビンの抗サイトメガロウイルス効果. 今日の移植 21 : 272, 2008

Medical*Online

6) Yoshimura N, Ushigome H, Matsuyama M, Nobori S, et al : The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment. Transplant Proc 44 : 140, 2012

PubMed

P.515 掲載の参考文献

1) 日本移植学会・日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2013) 2012年実施症例の集計報告 移植 48 (6) : 346-361, 2013

Medical*Online

2) 2013 Annual Data Report, UNITED STATES RENAL DATA SYSTEM http://www.usrds.org/adr.aspx

 

3) Undre NA, vanHoof J, Christiaans M, et al : Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. Transplant Proc 30 : 1299-1302, 1998

 

4) Mycophenolate mofetil prescribing information. F. Hoffmann-La Roche, Nutley (NJ), USA, 1998

 

5) Smak Gregoor PJM, van Gelder T, Hessec J, et al : Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporine : a cross-sectional study. Nephrol Dial Transplant 29 : 348-349, 1999

 

6) Staatz HE, Tett SE : Review : Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients. Clin Pharmacokinet 46 (1) : 13-58, 2007

 

7) 渡井至彦, 高田昌幸, 深見晴恵, 山本貴之, 他 : 名古屋第二赤十字病院におけるミコフェノール酸血中濃度モニタリング. 今日の移植 26 (2) : 121-126, 2013

Medical*Online

8) Arns W, Cibrik DM, Walker RG, et al : Therapeutic Drug Monitoring of Mycophenolic Acid in SolidOrgan Transplant Patients Treated With Mycophenolate Mofetil : Review of the Literature. Transplantation 82 : 1004-1012, 2006

 

9) van Gelder T, Silva HT, de Fijter JW, et al : Comparing mycophenolate mofetil regimens for de novo renal transplant recipients : the fixed-dose concentration-controlled trial. Transplantation 86 (8) : 1043-1051, 2008

 

10) van Gelder T, Tedesco Silva H, de Fijter JW, et al : Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid. Transplantation 89 (5) : 595-599, 2010

PubMed

11) Le Meur Y, Buchlerb M, Thierry A, et al : Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation. Am J Transplant 7 : 2496-2503, 2007

 

12) Knight SR, Morris PJ : Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review Transplantation 85 : 1675-1685, 2008

PubMed

P.517 掲載の参考文献

1) Calne RY, Rolles K, White DJ, et al : Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs : 32 kidneys, 2 pancreases, and 2 livers. Lancet 17 : 1033-1036, 1979

 

2) Halloran PF1, Helms LM, Kung L, Noujaim J, et al : The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68 : 1356-1361, 1999

 

3) Cole E1, Midtvedt K, Johnston A, et al : Recommendations for the implementation of Neoral C (2) monitoring in clinical practice. Transplantation 73 : S19-22, 2002

 

4) Bouchta NB, Ghisdal L, Abramowicz D, et al : Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation. Transplant Proc 37 : 1857-1860, 2005

PubMed

P.520 掲載の参考文献

1) Niioka T, Satoh S, Kagaya H, et al : Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. Transplantation 94 : 1013-1019, 2012

PubMed

2) Satoh S, Saito M, Inoue T, et al : CYP3A5*1 allele assoicated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allogaraft nephropathy in Jananese renal transplant recipients. Eur J Clin Pharmacol 65 : 473-481, 2009

 

3) Barraclough KA, Isbel NM, Johnson DW, et al : Onceversus twice-daily tacrolimus. Are the formulation truly equivalent? Drugs 71 : 1561-1577, 2011

 

4) Hardinger KL, Park JM, Schnitzler MA, et al : Pharmacokineticss of tacrolimus in kidney transplant recipients : twice daily versus once daily dosing. Am J Transplant 4 : 621-625, 2004

 

5) Satoh S, Kagaya H, Saito M, et al : Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients. Br J Clin Pharmacol 66 : 207-214, 2008

PubMed

P.523 掲載の参考文献

1) Diane C, Helio T, Anantharaman V, et al : Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 Months in renal transplantation. Transplantation 95 : 933-942, 2013

 

2) Robert M. Langer, Ronald H, Stefan V, et al : Everolimus plus early tacrolimus minimization : a phase III, randomized, open-label, multicenter trial in renal transplantation. Transplant Int 25 : 592-602, 2012

 

3) K budde, F Lehner, C sommerer, et al : Conversion from cyclosporine to everolimus at 4.5 months posttransplant : 3-year results from the randomized ZEUS study. Am J Transplant 12 : 1528-1540, 2012

 

4) Hallvard H, Lionel R, Daniel S, et al : Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus : a randomized, multicenter, 24-month study. Transplantation 92 : 410-418, 2011

 

5) Chadban SJ, Eris JM, Kanellis J, et al : A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients. Transplant Int 27 : 302-311, 2014

PubMed

P.526 掲載の参考文献

1) 薬品インタビューフォーム : スパニジン 2012 http://mink.nipponkayaku.co.jp/product/di/in_file/sedi_spai_in.pdf

 

2) 遠藤忠雄 : 腎移植に使用される薬剤 : デオキシスパガリン (塩酸グスペリムス). 腎と透析 41 (増刊号) : 642-644, 2006

 

3) 雨宮浩編 : デオキシスパガリン-新免疫抑制剤の基礎と臨床, 日本医学館, 東京, 1994

 

4) 清水朋一, 田邊一成 : デオキシスパガリン (塩酸グスペリムス). 腎移植のすべて 高橋公太編, メジカルビュー社, 東京, 2009

 

5) Takeuchi T, Iinuma H, Kunimoto S, et al : A new antitumor antibiotic, spergualin isolation and antitumor activity. J Antibiotics 34 : 1619-1621, 1981

PubMed

6) Nishimura K, et al : Mechanism of 15-deoxyspergualin I, Suppressive effect on the induction of alloreacitive secondary cytotoxic T lymphocytes in vivo and in vitro. Immunology 68 : 66-71, 1989

PubMed

7) Morikawa K, et al : The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producting cells. Transplantation 54 : 526-531, 1992

 

8) Nemoto K, et al : Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J Antibiotics 40 : 1062-1064, 1987

 

9) 雨宮浩, 他 : 腎移植後の難治性拒絶反応に対するNKT-01の治療効果-試験基準外症例に対する一般臨床試験-. 基礎と臨床 25 : 3501-3508, 1991

 

10) 林良輔, 他 : 新免疫抑制剤デオキシスパガリンの薬物動態に関する実験的研究. 腎と透析 32 : 315-318, 1992

 

11) 雨宮浩, 他 : 新しい免疫抑制剤NKT-01 (デオキシスパガリン) の腎移植後の拒絶反応に対する治療効果-前期第II相試験-. 移植 26 : 604-614, 1991

 

12) 雨宮浩, 他 : 腎移植後の拒絶反応治療に対するNKT-01の至適投与量設定のための臨床試験-後期第II相試験-. 移植 26 : 615-628, 1991

Medical*Online

P.528 掲載の参考文献

1) 中川由紀 : バシリキシマブ (CD25). 腎移植のすべて, 高橋公太編, メジカルビュー社, 東京, 2009

 

2) van den Berghe L : Introduction to transplant immunology and immunosuppression, pp58-59, Mosby-Wolf Medical Communication, London, 1999

 

3) Haba T, Uchida K, Katayama A, et al : Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation : a comparison between Japanese and non-Japanese patients. Transplant Proc 33 (7-8) : 3174-3175, 2001

 

4) Amlot PL, Rawlings E, Fernando ON, et al : Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation 60 (7) : 748-756, 1995

PubMed

5) Webster AC, Playford EG, Higgins G, Chapman JR, et al : Interleukin 2 receptor antagonists for renal transplant recipients : a meta-analysis of randomized trials. Transplantation 77 (2) : 166-176, 2004

PubMed

6) Lim WH, Chang SH, Chadban SJ, et al : Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients. Transplantation 88 (10) : 1208-1213, 2009

PubMed

7) United States Simulect Renal Study Group ; Kahan BD, Rajagopalan PR, Hall M : Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. Transplantation 67 (2) : 276-284, 1999

 

8) シムレクト静脈注用20 mg, 10 mg 医薬品インタビューフォーム (ノバルティスファーマ) http://product.novartis.co.jp/sil/if/if_sil20_20130419.pdf

 

9) Neuhaus P, Clavien PA, Kittur D, et al : Improved treatment response with basiliximab immunoprophylaxis after liver transplantation : results from a doubleblind randomized placebo-controlled trial. Liver Transpl 8 (2) : 132-142, 2002

PubMed

P.531 掲載の参考文献

1) Sawada T, Fuchinoue S, Teraoka S : Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 74 (9) : 1207-1210, 2002

 

2) Kohei N, Hirai T, Omoto K, et al : Chronic antibodymediated rejection is reduced by targeting B-cell immunity during an introductory period. Am J Transplant 12 (2) : 469-476, 2012

PubMed

3) Irei T, Ohdan H, Zhou W, et al : The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade : novel concept in preventing antibody-mediated rejection in ABOincompatible transplantation. Blood 110 : 4567-4575, 2007

 

4) Kim DH, Jung HD, Kim JG, et al : FCg-R3a gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma. Blood 108 (8) : 2720-2725, 2006

 

P.536 掲載の参考文献

1) Mourad G, Morelon E, Noel C, et al : The role of Thymoglobulin induction in kidney transplantation : an update. Clin Transplant 26 : E450-E464, 2012

PubMed

2) Genestier L, Fournel S, Flacher M, et al : Induction of Fas (Apo-1, CD95) -mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 91 : 2360-2368, 1998

PubMed

3) Preville X, Flacher M, Lemauff B, et al : Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 71 : 460-468, 2001

 

4) Gaber AO, First MR, Tesi RJ, et al : Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 66 : 29-37, 1998

PubMed

5) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S1-S155, 2009

 

6) Scientific Registry of Transplant Recipients HP. http://www.srtr.org/

 

P.539 掲載の参考文献

1) ネオーラル ; 医薬品インタビューフォーム 2013年4月改訂 (改訂第15版), http://www.info.pmda.go.jp/go/interview/2/300242_3999004M3021_2_NEO_1F.pdf

 

2) プログラフ ; 医薬品インタビューフォーム 2013年11月 (改訂第33版版), http://www.info.pmda.go.jp/go/interview/3/800126_3999014M3025_3_1F.pdf

 

3) グラセプター ; 医薬品インタビューフォーム 2013年11月 (改訂第13版), http://www.info.pmda.go.jp/go/interview/1/800126_3999014N1028_1_1F.pdf

 

4) セルセプト ; 医薬品インタビューフォーム 2013年2月 (改訂第17版), http://www.info.pmda.go.jp/go/interview/2/450045_3999017M1026_2_017_1F.pdf

 

5) 渡井至彦, 高田昌幸, 深見晴恵, 他 : 名古屋第二赤十字病院におけるミコフェノール酸血中濃度モニタリング. 今日の移植 26 (2) : 121-126, 2013

Medical*Online

6) サーティカン ; 医薬品インタビューフォーム 2013年11月改訂 (改訂第6版), http://www.info.pmda.go.jp/go/interview/1/300242_3999022F1028_2_CER_1F.pdf

 

P.543 掲載の参考文献

1) 大谷文雄, 木村彰方, 小林賢, 他編 : 移植・輸血検査学, 講談社サイエンティフィク, 東京, 2004

 

2) ASHI Laboratory Manual 4th edition

 

3) Vaidya S, Cooper TY, Avandsalehi J, et al : Improved flow cytometric detection of HLA alloantibodies using pronase : potential implications in renal transplantation. Transplantation 71 : 422-428, 2001

PubMed

4) Fujiwara K, Shimano K, Tanaka H, et al : Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang 96 : 244-251, 2009

PubMed

5) Pei R, Wang G, Tarsitani C, et al : Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol 59 : 313-322, 1998

 

6) LABScreen Product Insert (One Lambda)

 

P.546 掲載の参考文献

1) 日本移植学会 : 日本移植学会倫理指針, 2012

 

2) 日本移植学会 : 生体腎移植ガイドライン, 2008

 

P.549 掲載の参考文献

1) Delmonico F ; Council of Transplantation Society : A Report of the Amsterdam Forum On the Care of the Live Kidney Donor : Data and Medical Guidelines. Transplant 79 (6 suppl) : S53-66, 2005

 

2) The declaration of Istanbul on organ trafficking and transplant tourism. Clin J Am Soc Nephrol 3 : 1227-1231, 2008

PubMed

3) Okamoto M, Suzuki T, Fujiki M, et al : The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication : analysis at a single Japanese center. Transplantation 89 : 1391-1395, 2010

 

4) 佐々木秀郎, 相田紘一朗, 江東邦夫, 他 : CT volumetry による腎移植ドナー分腎機能比の推測. 腎移植症例集 2011, 高橋公太, 市川靖二編, 日本臨床腎移植学会監修, pp213-214, 2011

 

P.554 掲載の参考文献

1) 日本移植学会・日本臨床腎移植学会. 腎移植臨床登録集計報告 (2013). 移植48 : 346-361, 2013

 

2) 日本移植学会ホームページ ; http://www.asas.or.jp/jst/topics/info_20120720.html

 

3) 日本臓器移植ネットワークホームページ ; http://www.jotnw.or.jp/jotnw/law_manual/pdf/rec-kidney.pdf

 

4) Kusaka M, Kubota Y, Sasaki H, et al : Is pulsatile perfusion necessary for renal transplantation engrafting kidneys from cardiac death donors? Transplant Proc 38 : 3388-3389, 2006

PubMed

5) Hoshinaga K, Fujita T, Naide Y, et al : Early prognosis of 263 renal allografts harvested from non-heartbeating cadavers using an in situ cooling technique. Transplant Proc 27 : 703-706, 1995

 

P.558 掲載の参考文献

1) 日本移植学会・日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2013). 移植 48 : 346-361, 2013

Medical*Online

2) Metzger R, Delmonico F, Feng S, et al : Expanded criteria donors for kidney transplantation. Am J Transplant 3 : 114-125, 2003

PubMed

3) Kootstra G, Daemen JH, Oomen AP : Categories of non-heart-beating donors. Transplant Proc 27 : 2893-2894, 1995

PubMed

4) 日本臓器移植ネットワーク 2007年臓器提供・移植データブック, 野本亀久雄, 寺岡慧, 小中節子監修, 日本臓器移植ネットワーク編, pp219-226, 2008

 

5) 鈴木孝雄, 浅野武秀, 落合武徳, 他 : 死体内腎冷却灌流装置の開発. 移植 16 : 482-486, 1981

Medical*Online

P.561 掲載の参考文献

1) Kasiske BL, Cangro CB, Hariharan S, et al : The evaluation of renal transplantation candidates : clinical practice guidelines. Am J Transplant (suppl 2) : 3-95, 2001

 

2) Satterthwaite R, Ozgu I, Shidban H, et al : Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation 64 : 432-435, 1997

PubMed

3) KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney disease. Kidney Int 73 : S109, 2008

 

4) Gabriel MD : Handbook of Kidney Transplantation, Forth ed, p178, Lippincott Williams & Wilkins, Philadelphia, 2005

 

P.563 掲載の参考文献

1) Delmonico F ; Council of the Transplantation Society : A Report of the Amsterdam Forum On the Care of the Live Kidney Donor : Data and Medical Guidelines. Transplantation 79 : S53-66, 2005

PubMed

2) Vigneault CB, Asch WS, Dahl NK, Bia MJ : Should living kidney donor candidates with impaired fasting glucose donate? Clin J Am Soc Nephrol 6 : 2054-2059, 2011

PubMed

3) Kher A, Mandelbrot DA : The living kidney donor evaluation : focus on renal issues. Clin J Am Soc Nephrol 7 : 366-371, 2012

PubMed

P.566 掲載の参考文献

1) Hing A, Hicks M, Garlick S, et al : The effects of hormone resuscitation on cardiac function and hemodynamics in a porcine brain-dead organ donar model. Am J Transplant 7 (4) : 809-817, 2007

 

2) Weber M, Dindo D, Demartines N, et al : Kidney transplantation from donors without a heart beat. N Engl J Med 347 : 248-255, 2002

 

3) Trainor D, Borthwick E, Ferguson A : Perioperative management of the hemodialysis patient. Semin Dial 24 (3) : 34-326, 2011

 

P.578 掲載の参考文献

1) Ratner LE, Ciseck LJ, Moore RG, et al : Laparoscopic live donor nephrectomy : two cases. Transplant Proc 26 : 1047-1049, 1995

 

2) Based on OPTN/UNOS data as of June 30, 2008

 

3) Yuzawa K, Kozaki K, Shinoda, M, et al : Outcome of laparoscopic living donor nephrectomy : current status and trends in Japan. Transplant Proc 40 : 2115-2117, 2008

PubMed

4) 中島一朗 : 手術手技, 生体腎採取術, 鏡視下腎採取術. 腎移植のすべて, 高橋公太編, pp102-106, メジカルビュー社, 東京, 2009

 

5) Nakajima I, Iwadoh K, Koyama I, et al : Nine-year experience of 700 hand-assisted laparoscopic donor nephrectomies in Japan. Clin Transplant 26 : 797-807, 2012

 

6) Harper JD, Breda A, Leppert JT, et al : Experience with 750 consecutive laparoscopic donor nephrectomies-is it time to use a standardized classification of complications? J Urol 183 : 1941-1946, 2010

 

P.584 掲載の参考文献

1) 日本臓器移植ネットワークホームページ移植に関するデータ http://www.jotnw.or.jp/datafile/offer/2013.html

 

2) 相川厚, 剣持敬, 斉藤和英, 他 : 献腎摘出マニュアル Version 2006, p6, 11 12

 

3) 公益社団法人日本臓器移植ネットワーク コーディネーター業務基準書 (現地対応編) 2014年版第4章 p85, 89, 90

 

4) Baranski A : Surgical Technique of Abdominal Organ Procurement, pp45-64, Springer-Verlag, London Limited, London, 2009

 

P.591 掲載の参考文献

1) 宍戸清一郎 : 小児腎移植. スタンダード小児外科手術, 田口智章, 岩中督監修, pp374-377, Medical View社, 東京, 2013

 

2) Watson CJE, Friend PJ : Surgical technique of kidney transplantation. Kidney transplantation-Principles and Practice, 7th ed, Morris PJ, Knechtle SJ (eds), pp161-175, Elsevier Saunders, Philadelphia, 2013

 

P.594 掲載の参考文献

1) 渋谷祐一, 堀見忠司, 岡林孝弘, 他 : 複数腎動脈をもつドナー腎に対して, 下腹壁動脈を利用した生体腎移植の経験. 移植 38 : 95-98, 2002

 

2) 関利盛 : 複数腎動脈の再建術. 腎移植と血管外科, pp50-57, メジカルビュー社, 東京, 2001

 

3) 三浦正義, 関利盛, 原田浩, 他 : 移植腎血管異常に対する血行再建の臨床的検討. 日泌尿会誌 88 : 566-570, 1997

 

P.597 掲載の参考文献

1) Inoue T, Sato S, Saito M, et al : Correlation between pretransplant Dialysis duration, bladder capacity, and prevalence of Vesicoureteral reflux to the graft. Transplantation 92 : 311-315, 2011

 

2) 剣持敬, 西郷健一, 丸山通広, 他 : 特集知っておきたい最新の腎移植知識長期透析患者の腎移植の適応とその問題点. 腎と透析 65 : 363-367, 2008

 

3) Elela AA, Morsy A, Reyad, et al : Modified extravesical ureteral reimplantation technique for kidney transplants. Int Urol Nephrol 39 : 1005-1009, 2007

 

4) 望月保志, 酒井英樹, 錦戸雅春, 他 : ワークショップ腎移植の手技と周術期管理長期透析患者の献腎移植レシピエント手術手技とピットホール. 西日本泌尿器科 72 : 172-177, 2010

 

5) Mangus R, Haag BW : Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation : A metaanalysis. Am J Transplant 4 : 1889-1896, 2004

PubMed

6) Akoh JA, Tahawar R : Effect of ureteric stents on urological infection and graft function following renal transplantation. World J Transplant 24 : 1-6, 2013

 

7) Nie Z, Zhang K, Huo W, et al : Comparison of urological complications with primary ureteroureterostomy versus conventional ureteroneocystostomy. Clin Transplant 24 : 615-619, 2010

PubMed

8) Gallentine ML, Wright JR FH : Ligation of the native ureter in renal transplantation. J Urol 167 : 29-30, 2002

 

9) 佐々木秀郎, 相田紘一郎, 力石辰也, 他 : 廃用性萎縮膀胱症例に対する移植尿管-自己尿管端側吻合. 腎移植血管外科 22 : 63-67, 2010

 

10) Tsunoyama K, Ishida H, Tanabe T, et al : Bladder function of end-stage renal disease patient. Int J Urol 17 : 791-795, 2010

 

P.600 掲載の参考文献

1) 内田潤次 : 周術期における腎移植患者の体液管理. 体液・代謝管理 28 : 27-33, 2012

Medical*Online

2) Mullens W, Abrahams Z, Francis GS, Sokos G, et al : Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53 : 589-596, 2009

PubMed

P.605 掲載の参考文献

1) 日本移植学会・日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2013) 2012年実施症例の集計報告. 移植 48 : 346-361, 2013

Medical*Online

2) 日本移植学会・日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2010) -3 : 2009年経過追跡調査結果. 移植 45 : 608-620, 2010

Medical*Online

3) Mallon DH, Summers DM, Bradley JA, et al : Defining delayed graft function after renal transplantation : simple is best. Transplantation 96 : 885-889, 2013

 

4) Saito K, Takahara S, Nakagawa Y, et al : Obstacles of non-heart-beating donor kidney transplantation in Japan to date and future perspectives. Transplant Proc 45 : 2866-2870, 2013

PubMed

5) Abboud I, Viglietti D, Antonie C, et al : Preliminary results of transplantation of kidneys donated after cardiocirculatory determination of death : a French single-center experience. Nephrol Dial Transplant 27 : 2583-2587, 2012

 

P.608 掲載の参考文献

1) 日本移植学会・日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2013) 2012年実施症例の集計報告. 移植 48 : 346-361, 2013

Medical*Online

2) 日本泌尿器内視鏡学会 : 泌尿器腹腔鏡手術ガイドライン 5. 生体腎移植における腹腔鏡下ドナー腎摘除術のガイドライン. Japanese Journal of Endourology and ESWL 21 : 49-60, 2008

 

3) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会 : 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン, Medical Front International Limited, 東京, 2004

 

4) UTI共同研究会周術期感染予防ガイドライン作成ワーキンググループ : 泌尿器科領域における周術期感染予防ガイドライン. 日泌尿会誌 97 : 1-35, 2006

 

P.611 掲載の参考文献

1) 秋葉悦子 : 人格主義生命倫理学, pp5-84, 創文社, 東京, 2014

 

2) 日本救急医学会救急医療における終末期医療の在り方に関する委員会 : 救急医療における終末期医療に関する提言 (ガイドライン) について. 2007年11月 (http://www.jaam.jp/html/info/info-20080829.htm)

 

3) 秋山政人 : 臓器提供推進活動. 腎と透析 75 : 103-107, 2013

Medical*Online

4) 横田裕行 (主任研究者) : 平成17年度厚生科学研究費総合研究報告書「脳死下での臓器移植の社会基盤に向けての研究」2006年3月

 

5) 有賀徹 (主任研究者) : 平成8年度厚生労働科学研究費補助金特別研究事業「脳死の発生等に関する研究」2007年3月

 

6) 小野元 : 承諾から臓器提供までの家族対応. 臓器提供時の家族対応のあり方, 日本臨床救急医学会移植医療における救急医療のあり方に関する検討委員会編, pp53-56, へるす出版, 東京, 2011

 

P.614 掲載の参考文献

1) Davis CL : Preemptive transplantation and the transplant first initiative. Curr Opin Nephrol Hypertens 19 : 592-597, 2010

 

2) 服部元史 : Preemptive renal transplantation (先行的腎移植). 小児内科 39 : 916-918, 2007

Medical*Online

3) NAPRTCS 2010 Annual Transplant Report. https://web.emmes.com/study/ped/annlrep/annlrep.html

 

4) 服部元史, 佐古まゆみ, 金子徹治, 他 : 2006年-2011年末までの期間中に新規発生した20歳未満の小児末期腎不全患者の実態調査報告. 日児腎誌 26 : 154-164, 2013

 

5) Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, et al : Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 20 : 167-175, 2005

PubMed

P.619 掲載の参考文献

1) Vats AN, Donaidson L, Fine RN, et al : Pretransplant dialysis status and out come of renal transplantation in North American children : NAPRTCS study, Transplantation 69 : 1414-1419, 2000

 

2) Mange KC, Joffe MM, et al : Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344 : 726-731, 2001

 

3) 八木澤隆 : 我が国における先行的腎移植の現状と展望. 変貌する腎移植, 高橋公太編, pp19-27, 日本医学館, 東京, 2012

 

4) 中川由紀, 田崎正行, 齋藤和英, 高橋公太 : 移植医から見たpreemptive kidney transplantation. 今日の移植 23 (5) : 627-631, 2010

 

5) Ishikawa N, Yagisawa T, Sakuma Y, et al : Preemptive kidney transplantation of living related or unrelated donor-recipient combinations. Transplant Proc 40 : 2294-2296, 2008

PubMed

6) Akkina SK, Connaire JJ, Snyder JJ, et al : Earlier is not necessarily better in preemptive kidney transplantation. Am J Transplant 8 : 2071-2076, 2008

 

P.623 掲載の参考文献

1) 齋藤和英, 高橋公太 : わが国のABO血液型不適合腎移植の統計-第15回アンケート調査報告. 今日の移植 24 (6) : 589-600, 2011

Medical*Online

2) Takahashi K, Saito K, Takahara S, et al : The Japanese ABO-incompatible Kidney Transplantation Committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 : 1089-1096, 2004

PubMed

3) Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, et al : Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 70 (9) : 1331-1335, 2000

 

4) Shimmura H, Tanabe K, Ishida H, Tokumoto T, et al : Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation 80 (7) : 985-988, 2005

PubMed

5) Takahashi K, Agishi T, Oba S, et al : In : Extracorporeal plasma treatment for extending indication of kidney transplantation ABO-incompatible and preformed antibody-positive kidney transplantation. Therapeutic Plasmapheresis IX, pp61-63, ESAO Press, Cleveland, 1990

 

6) Saito K, Nakagawa Y, Suwa M, Kumagai N, et al : Pinpoint targeted immunosuppression : anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation 13 (2) : 111-117, 2006

PubMed

7) 高橋公太 : わが国のABO血液型不適合腎移植の統計-第12回アンケート調査報告. 今日の移植 21 (6) : 578-592, 2008

Medical*Online

P.627 掲載の参考文献

1) Stegall MD, Diwana T, Raghavaiah S, et al : Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients. Am J Transplant 11 : 2405-2413, 2011

 

2) Vo AA, Lukovsky M, Toyoda M, et al : Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359 : 242-245, 2008

PubMed

3) Montgomery RA, Lonze BE, King KE, et al : Desensitization in HLA-Incompatible Kidney Recipients and Survival. N Engl J Med 365 : 318-326, 2011

PubMed

4) Bentall A, Cornell LD, Gloor JM, et al : Five-year outcomes in living donor kidney transplants with a positive crossmatch. Am J Transplant 13 (1) : 76-85, 2013

PubMed

P.631 掲載の参考文献

1) 日本透析医学会 : わが国の慢性透析療法の現況 (2008年12月31日現在). 透析会誌 43 (1) : 1-35, 2010

 

2) 日本移植学会 : 腎臓, 臓器移植ファクトブック 2009, pp16-28, 2009 http://www.asas.or.jp/jst/

 

3) 日本臓器移植ネットワーク http://www.jotnw.or.jp/

 

4) 日本移植学会 http://www.asas.or.jp/jst/report_top.html

 

5) 日本臨床腎移植学会 http://www.jscrt.jp/ 腎移植臨床登録集計報告 2010.

 

P.634 掲載の参考文献

1) 日本透析医学会統計調査委員会 : 図説 わが国の慢性透析療法の現況 (2012年12月31日現在), 2013

 

2) 日本移植学会・日本腎移植臨床学会腎移植臨床登録集計報告 (2013) 2012年実施症例の集計報告. 移植 48 (6) ; 346-361, 2013

 

3) Wolfe RA, Ashby VB, Milford EL, Ojo AO, et al : Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 (23) : 1725-1730, 1999

PubMed

4) Cosio FG, Hickson LJ, Griffin MD, Stegall MD, et al : Patient survival and cardiovascular risk after kidney transplantation : the challenge of diabetes. Am J Transplant 8 (3) : 593-599, 2008

PubMed

5) Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, et al : Effect of waiting time on renal transplant outcome. Kidney Int 58 (3) : 1311-1317, 2000

PubMed

6) Orchard TJ, Dorman JS, Maser RE, Becker DJ, et al : Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39 (9) : 1116-1124, 1990

PubMed

7) Pugh JA, Medina R, Ramirez M : Comparison of the course to end-stage renal disease of type 1 (insulindependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 36 (10) : 1094-1098, 1993

PubMed

8) Gaston RS, Basadonna G, Cosio FG, Davis CL, et al : Transplantation in the diabetic patient with advanced chronic kidney disease : a task force report. Am J Kidney Dis 44 (3) : 529-542, 2004

PubMed

9) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (4 suppl 3) : S1-153, 2005

 

10) Leavey SF, Strawderman RL, Young EW, Saran R, et al : Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int 58 (5) : 2119-2128, 2000

PubMed

11) Siddqi N, Hariharan S, Danovitch G : Evaluation and Preparation of Renal Transplant Candidates. Handbook of Kidney Transplantation, Fourth ed, Lippincott Williams & Wilkins, Philadelphia, 2005

 

12) Yates CJ, Fourlanos S, Hjelmesaeth J, Colman PG, et al : New-onset diabetes after kidney transplantationchanges and challenges. Am J Transplant 12 (4) : 820-828, 2012

PubMed

P.638 掲載の参考文献

1) Marinaki S, Lionaki S, Boletis JN : Glomerular disease recurrence in the renal allograft : a hurdle but not a barrier for successful kidney transplantation. Transplant Proc 45 (1) : 3-9, 2013

 

2) 日本移植学会, 日本臨床腎移植学会 : 腎移植臨床登録集計報告 (2013) 2012年実施症例の集計報告. 移植 48 (6) : 346-361, 2013

Medical*Online

3) Suzuki K, Honda K, Tanabe K, et al : Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63 (6) : 2286-2294, 2003

PubMed

4) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S1-155, 2009

 

5) Mulay AV, van Walraven C, Knoll GA : Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 9 (4) : 804-811, 2009

PubMed

6) Kawamura T, Yoshimura M, Miyazaki Y, et al : A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant 2014 [Epub ahead of print]

 

P.640 掲載の参考文献

1) D'Agati VD, Kaskel FJ, Falk RJ : Focal segmental glomerulosclerosis. N Engl J Med 365 : 2398-2411, 2011

PubMed

2) Ponticelli C : Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant 25 : 25-31, 2010

PubMed

3) Fine RN : Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 22 : 496-502, 2007

PubMed

4) Gohh RY, Yango AF, Morrissey PE, et al : Preemptive plasmapheresis and recurrence of FSGS in highrisk renal transplant recipients. Am J Transplant 5 : 2907-2912, 2005

PubMed

5) Chikamoto H, Hattori M, Kuroda N, et al : Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence. Pediatr Transplant 16 : E286-290, 2012

 

6) 上田博章, 藤井寛, 菅原典子, 他 : 巣状分節性糸球体硬化症の腎移植後再発に対し血漿交換療法の継続にて部分寛解を維持している1例. 日小児腎不全会誌 32 : 116-118, 2012

 

7) Straatmann C, Kallash M, Killackey M, et al : Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Pediatr Transplant 18 : 29-34, 2014

PubMed

8) Cravedi P, Kopp JB, Remuzzi G : Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant doi : 10.1111/ajt. 12045, 2013

 

9) Wei C, El Hindi S, Li J, et al : Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17 : 952-960, 2011

PubMed

10) Wada T, Nangaku M, Maruyama S, et al : A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int 85 : 641-648, 2014

 

P.644 掲載の参考文献

1) Higashihara E, Nutahara K, Kojima M, et al : Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron 80 : 421-427, 1998

PubMed

2) Pirson Y, Chauveau D : Cerebral aneurysms. Polycystic kidney disease, Watson M, Torres V (eds), pp205-227, Oxford University press, Oxford, England, 1996

 

3) Yamamoto T, Watarai Y, Kobayashi T, et al : Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. Transplantation 93 : 794-798, 2012

PubMed

4) Stiasny B, Ziebell D, Graf S, et al : Clinical aspects of renal transplantation in polycystic kidney disease. Clin Nephrol 58 : 16-24, 2002

PubMed

5) Walz G, Budde K, Mannaa M, et al : Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363 : 830-840, 2010

PubMed

6) Kanaan N, Goffin E, Pirson Y, et al : Carbo-hydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 55 : 916-922, 2010

 

P.646 掲載の参考文献

1) Alport AC : Hereditary familial congenital haemorrhagic nephritis. Br Med J 1 : 504-506, 1927

PubMed

2) Barker DF, Hostikka SL, Zhou J, et al : Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248 : 1224-1227, 1990

PubMed

3) 日本移植学会, 日本小児腎移植臨床統計小委員会 : 本邦における小児腎移植-原因疾患に関する検討-. 移植 44 : 69-78, 2009

Medical*Online

4) Kashtan CE : Renal transplantation in patients with Alport syndrome. Pediatr Transplantation 10 : 651-657, 2006

PubMed

5) Gross O, Weber M, Fries JWU, et al : Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome : long-term risk, benefit and outcome. Nephrol Dial Transplant 24 : 1626-1630, 2009

PubMed

P.649 掲載の参考文献

1) Mendizabal S, Estornell F, Zamora I, Sabater A, et al : Renal transplantation in children with severe bladder dysfunction. J Urol 173 (1) : 226-229, 2005

PubMed

2) 宍戸清一郎 : IV 腎疾患と特殊な腎移植小児下部尿路障害. 腎移植のすべて, 高橋公太編, pp210-211, メジカルビュー社, 東京, 2009

 

3) Gonzalez R, Franc-Guimond J, Ludwikowski B : Transplantation and the abnormal bladder. Kidney transplantation-Principles and Practice, 7th ed (Morris PJ, Knechtle SJ (ed), pp176-190, Elsevier Saunders, Philadelphia, 2013

 

4) Rigamonti W, Capizzi A, Zacchello G, Capizzi V, et al : Kidney transplantation into bladder augmentation or urinary diversion : long-term results. Transplantation 80 (10) : 1435-1440, 2005

PubMed

P.653 掲載の参考文献

1) Kusumoto S, Tanaka Y, Ueda R, Mizokami M : Reactivation of hepatitis B virus following rituximabplus-steroid combination chemotherapy. J Gastroenterol 46 (1) : 9-16, 2011

 

2) Dervite I, Hober D, Morel P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 344 (1) : 68-69, 2001

 

3) 斉藤純, 矢澤浩治, 角田洋一, 細見昌弘, 他 : HCVRNA陽性ドナーに対しIFN療法を行い生体腎移植を施行した2例. 移植 41 (3) : 273-276, 2006

 

4) 中井滋, 政金生人, 重松隆, 濱野高行, 他 : わが国の慢性透析療法の現況 (2007年12月31日現在). 透析会誌 42 (1) : 1-45, 2009

 

5) Terrault NA, Adey DB : The kidney transplant recipient with hepatitis C infection : pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2 (3) : 563-575, 2007

PubMed

6) Baid-Agrawal S, Pascual M, Moradpour D, Frei U, et al : Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Medical Virol 18 (2) : 97-115, 2008

PubMed

7) Roth D, Zucker K, Cirocco R, Burke G, Ciancio G, et al : A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 61 (6) : 886-889, 1996

PubMed

8) Aroldi A, Lampertico P, Montagnino G, Lunghi G, et al : Natural history of hepatitis C virus infection in adult renal graft recipients. Transplant Proc 37 (2) : 940-941, 2005

PubMed

9) Sanai FM, Mousa D, Al-Mdani A, Al-Shoail G, et al : Safety and efficacy of peginterferon-alpha2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C. J Hepatol 58 (6) : 1096-1103, 2013

PubMed

10) Wei F, Liu J, Liu F, Hu H, et al : Interferon-based antiviral therapy for hepatitis C virus infection after renal transplantation : an updated meta-analysis. PLoS One 9 (4) : e90611, 2014

PubMed

11) 鈴木文孝, 林紀夫, 後藤章一郎, 熊田博光 : ゲノタイプ1型C型肝炎に対するシメプレビル (TMC435) のペグインターフェロン α-2b及びリバビリン併用療法 (CONCERTO-4試験). 肝臓 54 (suppl. 1) : A157, 2013

 

P.656 掲載の参考文献

1) Humar A, Snydman D : Cytomegalovirus in solid organ transplant recipients. Am J Transplant 9 (suppl 4) : S78-86, 2009

 

2) Khoury JA, Storch GA, Bohl DL, Schuessler RM, et al : Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 6 (9) : 2134-2143, 2006

PubMed

3) Reischig T, Jindra P, Hes O, Svecova M, et al : Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant 8 (1) : 69-77, 2008

PubMed

4) Paya C, Humar A, Dominguez E, Washburn K, et al : Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4 (4) : 611-620, 2004

PubMed

5) Humar A, Lebranchu Y, Vincenti F, Blumberg EA, et al : The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 10 (5) : 1228-1237, 2010

PubMed

6) Humar A, Paya C, Pescovitz MD, Dominguez E, et al : Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients. Am J Transplant 4 (4) : 644-649, 2004

 

7) Snydman DR : Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation. Transpl Infect Dis 3 (suppl 2) : 6-13, 2001

 

8) Sun HY, Wagener MM, Singh N : Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir : a systematic review. Am J Transplant 8 (10) : 2111-2118, 2008

PubMed

9) Small LN, Lau J, Snydman DR : Preventing postorgan transplantation cytomegalovirus disease with ganciclovir : a meta-analysis comparing prophylactic and preemptive therapies. Clin Infect Dis 43 (7) : 869-880, 2006

PubMed

10) Preiksaitis JK, Brennan DC, Fishman J, Allen U : Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 5 (2) : 218-227, 2005

PubMed

11) Schroeder R, Michelon T, Fagundes I, Bortolotto A, et al : Antigenemia for cytomegalovirus in renal transplantation : choosing a cutoff for the diagnosis criteria in cytomegalovirus disease. Transplant Proc 37 (6) : 2781-2783, 2005

PubMed

12) The TH, van der Bij W, van den Berg AP, van der Giessen M, et al : Cytomegalovirus antigenemia. Rev Infect Dis 12 (suppl 7) : S734-744, 1990

 

13) Masuho Y, Matsumoto Y, Sugano T, Fujinaga S, et al : Human monoclonal antibodies neutralizing human cytomegalovirus. J Gen Virol 68 (Pt 5) : 1457-1461, 1987

 

P.659 掲載の参考文献

1) 柏木征 : レトロウイルス疾患感染予防対策 血液媒介疾患の感染対策. 病理と臨床 11 (臨増) : 345-351, 1993

 

2) Toro C, Rodes B, Poveda E, Soriano V : Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human Tcell lymphotropic virus type I from a single donor. Transplantation 75 (1) : 102-104, 2003

PubMed

3) Nakamura N, Tamaru S, Ohshima K, Tanaka M, et al : Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc 37 (4) : 1779-1782, 2005

PubMed

4) Tsurumi H, Tani K, Tsuruta T, Shirato R, et al : Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol 41 (4) : 292-294, 1992

 

5) 猪瀬悠, 秋山茂, 望月温, 清水優, 他 : 生体腎移植後にHTLV-1関連脊髄症を発症した1例. 臨床神経学 50 (4) : 241-245, 2010

 

6) Matsuzaki T, Nakagawa M, Nagai M, Usuku K, et al : HTLV-I proviral load correlates with progression of motor disability in HAM/TSP : analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol 7 (3) : 228-234, 2001

 

7) Ijichi S, Izumo S, Eiraku N, Machigashira K, et al : An autoaggressive process against bystander tissues in HTLV-I-infected individuals : a possible pathomechanism of HAM/TSP. Med Hypotheses 41 (6) : 542-547, 1993

PubMed

P.662 掲載の参考文献

1) Englesbe M, Punch J, Armstrong D, et al : Single-center study of technical graft loss in 714 consecutive renal transplants. Transplantation 78 : 623-626, 2004

PubMed

2) Wilson C, Bhatti A, Rix D, et al : Routine intraoperative stenting for renal transplant recipients. Transplantation 80 : 877-882, 2005

PubMed

3) Dominguez J, Clase C, Maharati K, et al : Is routine ureteric stenting needed in kidney transplantation? a randomized trial. Transplantation 70 : 597-601, 2000

 

4) Lucewicz A, Wong G, Lam V, et al : Management of primary symptomatic lymphocele after kidney transplantation : a systematic review. Tranplantation 92 : 663-673, 2011

 

P.666 掲載の参考文献

1) 日本移植学会 : 生体腎移植ガイドライン

 

2) 日本臨床腎移植学会ガイドライン作成委員会 : 腎移植後サイトメガロウイルス感染症の診療ガイドライン 2011, 日本医学館, 東京, 2011

 

3) 日本泌尿器科学会泌尿器科領域における感染制御ガイドライン作成委員会 : 泌尿器科領域における周術期感染予防ガイドライン, 協和企画, 東京, 2007

 

4) Mangram AJ, Horan TC, Pearson ML, Silver LC, et al : Guideline for prevention of surgical site infection, 1999. Infect Cont Hosp Epidemiol 20 : 247-278, 1999

 

5) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S1-S155, 2009

 

6) Hirsh HH, Knowles W, Dickenmann M, et al : Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347 (15) : 488-496, 2002

 

P.671 掲載の参考文献

1) Fishman JA, Issa NC : Infection in organ transplantation : risk factors and evolving patterns of infection. Infect Dis Clin North Am 24 : 273-283, 2010

PubMed

2) Humar A, Michaels M ; AST ID Working Group on Infectious Disease Monitoring : American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6 : 262-274, 2006

 

3) Nishimura K, Uchida K, Fukuda Y, et al : Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients : multicenter study in Japan. Transplant Proc 44 : 147-149, 2012

PubMed

4) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S44-58, 2009

 

5) Batal I, Franco ZM, Shapiro R, et al : Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Hum Pathol 40 : 1312-1319, 2009

PubMed

6) Fabrizi F, Dulai G, Dixit V, et al : Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation : meta-analysis of clinical trials. Transplantation 77 : 859-864, 2004

PubMed

P.675 掲載の参考文献

1) Engelhard D : Bacterial infection. Transplant Infections, second ed, Bowden RA, et al (eds), pp225-273, Lippincott Williams and Wilkins, Philadelphia, 2003

 

2) 東京女子医科大学腎センター脳死腎移植マニュアル

 

P.678 掲載の参考文献

1) Pappas PG, Alexander BD, Andes DR, et al : Invasive fungal infections among organ transplant recipients : results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50 : 1101-1111, 2010

PubMed

2) 深在性真菌症のガイドライン作成委員会 : 臓器移植領域. 深在性真菌症の診断・治療のガイドライン 2014, 第1版, 協和企画, 東京, 2014

 

3) Pappas PG, Kauffman CA, Andes D, et al : Clinical practice guidelines for the management of candidiasis : 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 (5) : 503-535, 2009

 

4) Walsh TJ, Anaissie EJ, Denning DW, et al : Treatment of aspergillosis : clinical practice guidelines of the infectious Diseases Society of America. Clin Infect Dis 46 (3) : 327-360, 2008

 

5) Perfect JR, Dismukes WE, Dromer F, et al : Clinical practice guidelines for the management of cryptococcal : 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50 (3) : 291-322, 2010

 

P.682 掲載の参考文献

1) Yale SH, Limper AH : Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome : associated illness and prior corticosteroid therapy. Mayo Clin Proc 71 (1) : 5-13, 1996

PubMed

2) Magne D, Angoulvant A, Botterel F, Bouges-Michel C, et al : Pneumocystosis : a network survey in the Paris area 2003-2008. Eur J Clin Microbiol Infect Dis 30 (5) : 673-675, 2011

PubMed

3) Maini R, Henderson KL, Sheridan EA, Lamagni T, et al : Increasing Pneumocystis pneumonia, England, UK, 2000-2010. Emerging Infectious Diseases 19 (3) : 386-392, 2013

 

4) ニューモシスチス肺炎研究会編 : ニューモシスチス肺炎のすべて, 克誠堂出版, 東京, 2013

 

5) de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, et al : An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients : interhuman transmission or a common environmental source? Clin Infec Dis 44 (9) : 1143-1149, 2007

PubMed

6) Lufft V, Kliem V, Behrend M, Pichlmayr R, et al : Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 62 (3) : 421-423, 1996

PubMed

7) Goto N, Oka S : Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis 13 (6) : 551-558, 2011

PubMed

8) Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, et al : Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIVinfected patients. Emerging Infectious diseases 10 (10) : 1766-1773, 2004

PubMed

9) Choukri F, Menotti J, Sarfati C, Lucet JC, et al : Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clinical Infect Dis 51 (3) : 259-265, 2010

 

10) Le Gal S, Damiani C, Rouille A, Grall A, et al : A cluster of Pneumocystis infections among renal transplant recipients : molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii. Clin Infect Dis 54 (7) : e62-71, 2012

PubMed

11) Yazaki H, Goto N, Uchida K, Kobayashi T, et al : Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients : P. jiroveci is contagious to the susceptible host. Transplantation 88 (3) : 380-385, 2009

 

12) Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, et al : Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 11 : 76, 2011

PubMed

13) Martin SI, Fishman JA : Pneumocystis pneumonia in solid organ transplant recipients. Am J Transplant 9 (suppl 4) : S227-233, 2009

 

14) Schmoldt S, Schuhegger R, Wendler T, Huber I, et al : Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol 46 (3) : 966-971, 2008

PubMed

P.686 掲載の参考文献

1) Foley RN, et al : Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 : 112-119, 1998

 

2) USRDS annual report, 2012

 

3) Pilmore H, et al : Reduction in cardiovascular death after kidney transplantation. Transplantation 89 : 851-857, 2010

PubMed

4) 日本臨床腎移植学会・腎移植臨床登録集計報告 2011

 

5) Liefeldt L, et al : Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transplant Int 23 : 1191-1204, 2010

PubMed

6) Meier-Kriesche HU, et al : Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End-Stage Renal Disease. Am J Transplant 4 : 1662-1668, 2004

PubMed

7) Aalten J, et al : Associations between pre-kidneytransplant risk factors and post-transplant cardiovascular events and death. Transplant Int 21 : 985-991, 2008

 

8) Joki N, et al : Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 12 : 718-723, 1997

PubMed

9) Charytan D, et al : Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 49 : 409-416, 2007

PubMed

10) Seyahi N, et al : Progression of coronary artery calcification in renal transplant recipients. Nephrol Dial Transplant 27 : 2101-2107, 2012

PubMed

11) Meier-Kriesche HU, et al : Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 75 : 1291, 2003

 

12) Halimi JM, et al : Respective Predictive Role of Urinary Albumin Excretion and Nonalbumin Proteinuria on Graft Loss and Death in Renal Transplant Recipients. Am J Transplant 7 : 2775-2781, 2007

PubMed

13) Morales E, et al : Treatment with calcimimetics in kidney trunsplantation. Transplant Rev 24 : 79-88, 2010

PubMed

14) Abbud-Filho M, et al : A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation 83 : S1-22, 2007

PubMed

15) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 : 1-157, 2009

 

P.690 掲載の参考文献

1) Opelz G, Wujciak T, Ritz E : Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 53 : 217-222, 1998

PubMed

2) Hauberg M, KoschM, Harmelink P, Barenbrock M, et al : Sympathetic nerve activity in end stage renal disease. Circulation 106 : 1974-1979, 2002

 

3) Formica RN Jr, Friedman AL, Lorber MI, Smith JD, et al : A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrol Dial Transplant 21 : 1389-1394, 2004

 

4) Tsai JP, Lian JD, Wu SW, et al : Long term impact of pretransplant and post transplant diabetes mellitus on kidney transplant outcomes. World J Surg 35 : 2818-2825, 2011

 

5) Bia M, Abey D, Bloom RD, et al : KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Kidney Dis 56 : 189-218, 2010

 

6) Marcen R : Cardiovascular risk factors in renal transplantation-current controversies. Nephrol Dial Transplant 21 (suppl 3) : iii38-41, 2006

 

7) Jardine AG, Holdaas H, Fellstrom B, et al : Fluvastatin prevents cardiac death and myocardial infarction in transplant recipients : Post-hoc subgroup analysis of the ALERT study. Am J Transplant 4 : 988, 2004

PubMed

8) Woodle ES, First MR, Pirsch J, et al : A prospective, randomized, double-blind, placebo-controlled multicenter trial compering early (7day) corticosteroid cessation versus long-term, low dose corticosteroid therapy. Ann Surg 248 : 564-577, 2008

 

9) Yamahara K, Kume S, Koya D, et al : Obesitymediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol 24 : 1769-1781, 2013

PubMed

10) Guida B, Trio R, Laccetti R, Nastasi A, et al : Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation. Nephrol Dial Transplant 22 : 3304-3310, 2007

PubMed

P.694 掲載の参考文献

1) Stratta P, Morellini V, Musetti C, et al : Malignancy after kidney transplantation : results of 400 patients from a single center. Clin Transplant 22 : 424-427, 2008

PubMed

2) Chapman JR, Webster AC : Cancer after renal transplantation : the next challenge. Am J Transplant 4 : 841-842, 2004

PubMed

3) Braun WE, Yadlapalli NG : The spectrum of longteam renal transplantation : outcomes, complications and clinical studies. Transplant Rev 16 : 22-50, 2002

 

4) 今西正昭, 国方聖司, 秋山隆弘, 栗田孝 : 当科における腎移植後の悪性腫瘍7例の検討および本邦における腎移植後の悪性腫瘍の統計. 移植 31 (2) : 100-107, 1996

Medical*Online

5) Hoshida Y, Tsukuma H, Yasunaga Y, et al : Cancer risk after renal transplantation in Japan. Int J Cancer 71 : 517-520, 1997

PubMed

6) Kasiske BL, Snyder JJ, Gilbertson DT, et al : Cancer after kidney transplantation in the United States. Am J Transplant 4 : 905-913, 2004

PubMed

P.698 掲載の参考文献

1) Komaba H, Koizumi M, Fukagawa M : Parathyroid resistance to FGF23 in kidney transplant recipients : back to the past or ahead to the future? Kidney Int 78 : 953-955, 2010

 

2) KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD). Kidney Int 76 (suppl 113) : S1-S130, 2009

 

3) 日本透析医学会ワーキンググループ : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 透析会誌 45 : 301-356, 2012

 

4) Taniguchi M, Tokumoto M, Matsuo D, et al : Persistent hyperparathyroidism in renal allograft recipients : vitamin D receptor, calcium-sensing receptor, and apoptosis. Kidney Int 70 : 363-370, 2006

PubMed

5) Evenepoel P : Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant Recipients. Semin Nephrol 33 (2) : 191-203, 2013

PubMed

6) Evenepoel P, Claes K, Kuypers D, et al : Natural history of parathyroid function and calcium metabolismafter kidney transplantation : a single-centre study Nephrol Dial Transplant 19 : 1281-1287, 2004

 

7) Evenepoel P, Claes K, Kuypers DR, et al : Parathyroidectomy after successful kidney transplantation : a single centre study. Nephrol Dial Transplant 22 : 1730-1737, 2007

PubMed

8) Kawarazaki H, Shibagaki Y, Fukumoto S, et al : Natural History of Mineral and Bone Disorders After Living-Donor Kidney Transplantation : A One-Year Prospective Observational Study. Ther Apher Dial 15 : 481-487, 2011

PubMed

P.701 掲載の参考文献

1) Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group : KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (suppl 3) : S1-155, 2009

 

2) 日本臨床腎移植学会 : 腎移植後内科・小児科系合併症の診療ガイドライン 2011 http://www.jscrt.jp/pdf_file/guide2011.pdf (2014年3月アクセス)

 

3) Ibrahim HN1, Foley R, Tan L, Rogers T, et al : Longterm consequences of kidney donation. N Engl J Med 360 (5) : 459-469, 2009

 

4) 長浜正彦 : 腎移植とチーム医療 : 移植内科医の立場. 臨牀透析 28 (11) : 1491-1495, 2012

 

P.706 掲載の参考文献

1) DiMartini AF, Dew MA, Trzepacz PT : Organ transplantation. American Psychiatric Publishing Textbook of Psychosomatic Medicine, Levenson JL (ed), pp675-700, American Psychiatric Publishing, Washington, DC, 2005

 

2) Nishimura K, Kobayashi S, Sugawara H, et al : Psychiatric consultation after kidney transplantation : a 10-year single-center study including outpatients in Japan. Int J Psychiatr Med 43 : 197-209, 2012

 

3) Dobbels F, Skeans MA, Snyder JJ, et al : Depressive disorder in renal transplantation : an analysis of Medicare claims. Am J Kidney Dis 51 : 819-828, 2008

PubMed

4) Novak M, Molnar MZ, Szeifert L, et al. : Depressive symptoms and mortality in patients after kidney transplantation : a prospective prevalent cohort study. Psychosom Med 72 : 527-534, 2010

PubMed

5) 日本総合病院精神医学会・臓器移植関連委員会 (主担当 : 西村勝治) : 生体臓器移植ドナーの意思確認に関する指針. 日本総合病院精神医学会治療指針 6. 星和書店, 東京, 2013

 

6) Dew MA, Switzer GE, DiMartini AF, et al. : Psychosocial aspects of living organ donation. Living Donor Organ Transplantation, Tan H, Marcos A, Shapiro R (eds), pp7-26, Informa Healthcare, New York, 2007

 

P.708 掲載の参考文献

1) Brescia MJ, Cimino JE, Appel K, Hurwich BJ : Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275 : 1089-1092, 1996

 

2) Patard JJ, Bensalah K, Lucas A, Rodriguez A, et al : Management of vascular access for hemodialysis after successful kidney transplantation. Scand J Urol Nephrol 36 : 373-376, 2001

 

3) Glowinski J, Malyszko J, Glowinska I, Mysliwied M : To close or not close : fistula ligation and cardiac function in kidney allograft recipients. Pol Arch Med Wewn 122 : 348-351, 2012

PubMed

P.712 掲載の参考文献

1) 日本移植学会 : 臓器移植ファクトブック 2009

 

2) 日本移植学会 : 臓器移植ファクトブック 2012

 

3) Weinhandl ED, et al : Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21 : 499-506, 2010

PubMed

4) 日本腎臓学会 : エビデンスに基づくCKD診療ガイドライン 2013, 東京医学社, 東京, 2013

 

5) 窪田基予子, 松野直徒 : 透析再開を要する患者心理とメンタルケア. 臨牀透析 22 (10) : 1365-1370, 2006

 

P.716 掲載の参考文献

1) 移植希望の登録から移植を受けるまで. 日本臓器移植ネットワークホームページ. http://www.jotnw.or.jp/transplant/flow.html

 

P.720 掲載の参考文献

1) 横田裕行 (班長), 他 ; 脳死判定基準のマニュアル化に関する研究班 : 法的脳死判定マニュアル, 平成22年度厚生労働科学研究費補助金厚生労働科学特別研究事業, (研究代表者有賀徹), p1, 2010

 

2) 小野元 : グリーフケアの意義. 腎移植のすべて, 高橋公太編, pp52-53, メジカルビュー社, 東京, 2009

 

3) 秋山政人 : 臓器提供推進活動 (Donor Action). 医療ジャーナル 49 (9) : 101-105, 2013

 

書評を投稿する